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Abstract 
Seven experiments were conducted to estimate the optimal standardized ileal digestible 
(SID) lysine:ME ratio for growing and finishing pigs. Experiment 1 determined an optimal SID 
lysine:ME ratio of 3.16 g/Mcal for 38 to 65 kg gilts. Experiment 2 reported an optimal level of 
2.58 g SID lysine/Mcal ME for 55 to 80 kg gilts. Experiment 3 determined an optimal SID 
lysine:ME ratio of 2.55 g/Mcal for 85 to 110 kg gilts. In Exp. 4 and 5, growth rates were 
improved with porcine circovirus type 2 vaccine, with the optimal SID lysine:ME ratio for 38 to 
65 kg gilts and barrows being 2.99 and 3.36 g SID lysine/Mcal ME, respectively. In Exp. 6 and 
7, the optimal SID lysine:ME ratio was 1.86 and 2.61 g/Mcal for 102 to 125 kg gilts and 98 to 
118 kg barrows, respectively. These trials indicate the optimal SID lysine:ME ratio for 
commercial growing and finishing pigs has increased compared with earlier estimates.  
Four experiments were also performed to determine the effect of copper (Cu) and zinc 
(Zn) supplementation on growth performance of weanling pigs.  In Exp. 1, both 3,000 ppm Zn 
from zinc oxide (ZnO) and 150 ppm Cu from tri-basic copper chloride (TBCC) independently 
improved growth performance in weanling pigs due to increased feed intake. Similar results were 
observed in Exp. 2, where 3,000 ppm Zn from ZnO increased ADG and ADFI. Also, 125 ppm 
Cu from copper sulfate (CuSO4) increased growth rate due to enhanced feed intake, with Cu 
supplementation from TBCC offering intermediate results to CuSO4 and no Cu supplementation. 
For the first 28-d of Exp. 3, similar additive responses were observed to adding Cu and Zn to the 
diets of weanling pigs. However, from d 28 to 42 the combined use of Cu and Zn produced 
decreased performance compared each used singularly. Similarly in Exp.4, CuSO4 and ZnO 
improved growth performance, however the benefit was not additive. These trials showed growth 
promoting advantages to adding Cu and Zn to weanling diets, but additive responses were 
inconsistent. 
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CHAPTER 1 - Effects of increasing dietary standardized ileal 
digestible lysine:ME ratio for gilts grown in a commercial finishing 
environment  
Abstract 
Three experiments were conducted to observe the effects of increasing dietary 
standardized ileal digestible (SID) lysine:ME ratio for growing and finishing gilts. Diets in all 3 
experiments were corn-soybean meal based and contained 0.15% L–Lysine HCl and 3% added 
fat from choice white grease. Desired SID lysine:ME levels were achieved by altering levels of 
corn and soybean meal in the diet. Each experiment consisted of 6 treatments with 7 pens per 
treatment and approximately 27 gilts (PIC 337 × 1050) per pen. In Exp. 1, 1,085 gilts (initially 
38.2 kg) were fed SID lysine:ME ratios of 2.01, 2.30, 2.58, 2.87, 3.16, or 3.45 g/Mcal for 28 d. 
As the SID lysine:ME ratio increased, ADG, G:F, feed cost per kilogram of gain, and income 
over feed cost (IOFC) improved (quadratic, P < 0.003) with optimal performance and economic 
responses reached at the SID lysine:ME ratio of 3.16 g/Mcal. Gilts in this trial required 
approximately 21.8 g of SID lysine intake per kilogram of BW gain from 38 to 65 kg. In Exp. 2, 
1,092 (initially 55.2 kg) gilts were fed SID lysine:ME ratios of 1.89, 2.12, 2.35, 2.58, 2.81, or 
3.04 g/Mcal for 28 d. Average daily gain, G:F, and IOFC improved (linear, P < 0.02) as SID 
lysine:ME ratio increased, with minor differences at levels above 2.58 g/Mcal. Gilts in this trial 
required approximately 19.6 g SID lysine per kilogram of BW gain from 55 to 80 kg to 
maximize growth and economic criteria. In Exp. 3, 1,080 gilts (initially 84.1 kg) were fed SID 
lysine:ME ratios of 1.55, 1.75, 1.95, 2.05, 2.35, or 2.55 g/Mcal for 29 d. As the SID lysine:ME 
ratio increased, ADG, G:F, feed cost per kilogram of gain, and IOFC improved (linear, P < 
0.001); performance and economic responses were maximized at the highest SID lysine:ME ratio 
of 2.55 g/Mcal ME. Gilts in this trial required 23.0 g SID lysine per kilogram of BW gain from 
85 to 110 kg. The equation SID lysine:ME ratio = -0.011 × BW, kg + 3.617 estimates the 
optimal SID lysine:ME ratios for growth and economic performance for gilts (PIC 337 × 1050) 
in this commercial finishing environment. These studies showed both economic and performance 
advantages to increasing the SID lysine:ME ratio for growing and finishing gilts over previously 
reported optimal levels. 
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Introduction 
Evaluating lysine requirements of the current high-lean pig genotypes is essential for 
generating cost-effective diets for growing and finishing pigs. Lysine requirements have been 
reported for lean genotypes (Cline et al., 2000; De La Llata et al., 2007; Main et al., 2008), and 
prediction models have been generated to estimate the lysine requirement from growth and 
changes in body composition (Schinckel and de Lange, 1996; NRC, 1998; Smith et al., 1999). 
These models use protein and lipid accretion and then calculate the energy requirement to meet 
the animal’s maintenance needs and compositional changes. An ideal standardized ileal 
digestible (SID) lysine:ME ratio can be estimated on the basis of the requirement for lysine as 
well as energy. In addition, the optimal SID lysine:ME ratio of a diet can be used over a range of 
dietary energy levels (Chiba et al., 1991; Bikker et al., 1994; De La Llata et al., 2001).  
Several non-dietary factors, including gender, genotype, health status, and environmental 
conditions, affect the lysine requirement for growing and finishing pigs (Baker, 1986; Campbell 
and Taverner, 1988; Friesen et al., 1994a; Williams et al., 1997). Therefore, empirical estimates 
under actual commercial production conditions are essential for confirming modeled estimates. 
Reevaluation of the requirements is also needed as progress is made in genetic lines. Thus, our 
objective was to reevaluate  the optimal SID lysine:ME ratio for gilts in a commercial 
environment previously reported by Main et al. (2008). 
Materials and Methods 
General 
All practices and procedures used in these experiments were approved by the Kansas 
State University Institutional Animal Care and Use Committee. 
Three experiments were conducted to evaluate the effects of increasing the SID 
lysine:ME ratio over a variety of weight ranges of growing and finishing gilts (337 × 1050; PIC, 
Hendersonville, TN) in a commercial finishing environment. All pigs received 2 full doses of 
commercially available porcine circovirus type 2 (PCV2) vaccine (Circumvent PCV, Intervet 
Inc., Millsboro, DE) while in the nursery. Upon placement into the finisher and before the 
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beginning of each experiment, pigs were placed on diets that met or exceeded the NRC (1998) 
nutrient requirements. These studies were conducted at a commercial finishing site in 
southwestern Minnesota. The barns were double curtain sided with completely slatted flooring 
and a deep pit for manure storage. The research barns contain 48 pens (3.05 × 5.49 m); each pen 
contained a 5-hole conventional dry feeder (STACO, Inc., Schaefferstown, PA) and a cup 
waterer to allow ad libitum consumption of feed and water. An automated feeding system 
(FeedPro; Feedlogic Corp., Willmar, MN) was used to deliver and record feed amounts on an 
individual pen basis. These studies were conducted in the same facilities with the same genetic 
lines as previous studies by De La Llata et al. (2007) and Main et al. (2008).  
All dietary treatments were corn-soybean meal based with 0.15% L-lysine HCl and 3% 
added fat in the form of choice white grease. Treatment SID lysine:ME ratios were achieved by 
replacing corn with soybean meal. Dietary nutrient values for treatments were determined by 
using ingredient values from the NRC (1998). All other nutrients were formulated to meet or 
exceed the animals’ requirements (NRC, 1998). Test diets were sampled in each experiment, and 
a subsample of each diet was analyzed for amino acid concentrations. Amino acid analysis was 
performed by Ajinimoto Heartland LLC (Chicago, IL) by HPLC (AOAC, 2000).  
In each experiment, pens of pigs were allotted to 1 of 6 dietary treatments in a completely 
randomized design with 7 pens per treatment. Each pen contained 24 to 27 pigs, and treatments 
were allotted to maintain equal average initial pen counts across dietary treatments. During each 
experiment, pig weights (by pen) and feed disappearance were determined at approximately 14-d 
intervals to determine ADG, ADFI, G:F, daily SID lysine intake, SID lysine intake per kilogram 
of gain, feed cost per kilogram of gain, and income over feed cost (IOFC). Feed costs were 
determined by valuing corn and 46.5% soybean meal at $204.97 and $385.80 per 1000 kg, 
respectively. Income over feed cost (IOFC) was calculated by assessing a value to the weight 
gain per pig ($132 per 100 kg) during the trial and subtracting the feed costs incurred during the 
trial on a per-pig basis.  
Experiment 1 
A total of 1,085 (38 to 65 kg) gilts were used in this 28-d study. Dietary treatments were 
formulated to SID lysine:ME ratios of  2.01, 2.30, 2.58, 2.87, 3.16, and 3.45 g/Mcal, which 
correspond to dietary SID lysine levels of 0.70, 0.80, 0.90, 1.00, 1.10, and 1.20% (Table 1). Pigs 
4 
 
in this trial were negative for porcine reproductive and respiratory syndrome virus (PRRSv) at 
weaning.  
Experiment 2 
A total of 1,092 (55 to 80 kg) gilts were used in this 28-d growth trial. Dietary treatments 
were formulated to SID lysine:ME ratios of 1.89, 2.12, 2.35, 2.58, 2.81, and 3.04 g/Mcal, which 
correspond to dietary SID lysine levels of 0.66, 0.74, 0.82, 0.90, 0.98, and 1.06% (Table 2). To 
maintain a minimum SID threonine:lysine ratio of 62% and a SID methionine and 
cysteine:lysine ratio of 58%, L-threonine and DL-methionine were added as needed. Pigs in this 
trial were PRRSv positive at weaning.  
Experiment 3 
A total of 1,080 (84 to 110 kg) gilts were used in this 29-d experiment. Dietary treatments 
were formulated to SID lysine:ME ratios of 1.55, 1.75, 1.95, 2.15, 2.35, and 2.55 g/Mcal, which 
correspond to dietary SID lysine levels of 0.54, 0.61, 0.68, 0.75, 0.82, and 0.89% (Table 3). To 
maintain a minimal SID threonine:lysine ratio of 62%, L-threonine was added as needed. Pigs in 
this trial were PRRSv negative at weaning.  
Statistical Analysis 
In each experiment, treatments were arranged in a completely randomized design. 
Analysis of variance was performed on the data from each experiment by using the MIXED 
procedure of SAS version 9.1 (SAS Inst. Inc., Cary, NC) with pen as the experimental unit in 
each experiment. Dietary lysine treatments were treated as fixed factors in the model, and 
contrast statements were then used to evaluate linear and quadratic polynomial effects associated 
with increasing the dietary SID lysine:ME ratio. Responses having a significant quadratic 
response were analyzed for a breakpoint according to procedures described by Robbins et al. 
(2006).  Breakpoint estimates were determined using a one-slope or two-slope broken-line 
regression model using the NLIN procedure of SAS (Robbins et al., 2006). 
Results and Discussion 
Analyzed amino acid levels for diets from Exp. 1, 2, and 3 are shown in Tables 4, 5, and 
6, respectively. Formulated diet values are included in parentheses. For each experiment, 
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analyzed concentrations of amino acids for the feed samples collected were similar to calculated 
total values (within the acceptable limits for analytical variation).  
In Exp. 1 (38 to 65 kg gilts), ADG and G:F improved (quadratic, P < 0.003, Table 7) with 
increasing SID lysine:ME ratios, with the greatest improvement through 3.16 g/Mcal. Broken-
line analysis showed breakpoints of 2.97 and 3.01 g SID lysine/Mcal ME for ADG and G:F, 
respectively. Although the magnitude of response was relatively small, ADFI decreased (linear, 
P = 0.04) with increasing SID lysine:ME ratio. This decrease in feed intake may be related to the 
increases in dietary protein level or the proportion of soybean meal incorporated in the diet. Main 
et al. (2008) observed similar decreases in feed intake as lysine increased in the diet of 35 to 60 
kg gilts when soybean meal was used as the amino acid source. Daily SID lysine intake 
increased (linear, P < 0.004) with increasing dietary lysine. Lysine intake per kilogram of gain 
increased (quadratic, P = 0.001) with increasing dietary lysine. Optimal performance was 
achieved at 3.16 g SID lysine/Mcal ME when pigs consumed 21.8 g SID lysine per kilogram of 
BW gain. Feed cost per kilogram of gain decreased (quadratic, P = 0.001) with increasing SID 
lysine:ME ratios, and IOFC increased (quadratic, P = 0.001) with increasing SID lysine:ME 
ratio; the greatest return was achieved at 3.16 g lysine/Mcal. In this experiment, optimal 
economic and performance response criteria occurred at similar SID lysine:ME ratios. Main et 
al. (2008) observed a slightly lower optimal total lysine:ME ratio of 3.23 g/Mcal (2.84 g SID 
lysine/Mcal ME) when gilts consumed 21.3 g SID lysine per kilogram of BW gain. Friesen et al. 
(1994b) also evaluated the lysine requirement for 34 to 55 kg gilts and reported that performance 
was maximized at 2.75 g apparent ileal digestible (AID) lysine/Mcal ME, or approximately 2.95 
g SID lysine/Mcal ME by utilizing the NRC (1998) digestibility coefficients for corn-soybean 
meal diets. Results of Exp. 1 revealed advantages to increasing the SID lysine:ME ratio above 
levels reported as optimal in previous experiments.  
In Exp. 2 (55 to 80 kg gilts), ADG, G:F, and final weight improved (linear, P < 0.05, 
Table 8) as SID lysine:ME ratio increased in the diet. The greatest improvement in ADG and 
G:F was observed as SID lysine:ME ratio increased to 2.58 g SID lysine/Mcal ME, and there 
was a small numeric increase in ADG at 2.81g SID lysine/Mcal ME. No differences were 
detected (P > 0.10) for ADFI. Therefore, daily SID lysine intake increased (linear, P = 0.001) as 
dietary SID lysine levels increased. Standardized ileal digestible lysine intake per kilogram of 
gain also increased (linear, P = 0.001) as lysine density of the diets increased. Because optimal 
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growth performance occurred at 2.58 g SID lysine/Mcal ME, approximately 19.6 g SID lysine 
were required for each kilogram of gain. No differences were observed (P > 0.10) for feed cost 
per kilogram of gain; however, IOFC increased (linear, P = 0.02) as SID lysine:ME ratio 
increased. Similar to the growth response, the highest IOFC was for pigs fed the diet containing 
2.58 g SID lysine/Mcal ME. These data illustrate that 2.58 g SID lysine/Mcal ME provides the 
optimal growth and economic return for 55 to 80 kg gilts. Main et al. (2008) determined a 
slightly lower optimal requirement of 2.44 g SID lysine/Mcal ME for 60 to 85 kg gilts, which 
translated to 21.0 g SID lysine per kilogram of gain. Friesen et al. (1994b), however, observed a 
slightly higher optimal requirement of 2.46 g AID lysine/Mcal ME (2.72 g SID lysine/Mcal ME) 
in 55 to 72.5 kg gilts. Therefore, the optimal SID lysine:ME ratio from Exp. 2 was only slightly 
numerically greater than that reported in previous trials. 
In Exp. 3 (84 to 110 kg gilts), ADG and G:F improved (linear, P < 0.001, Table 9) with 
increasing SID lysine:ME ratio. Feed intake was not (P > 0.10) affected by increasing dietary 
lysine. Final weight, daily SID lysine intake, and SID lysine intake per kilogram of gain 
increased (linear, P < 0.001) with increasing SID lysine. Feed cost per kilogram of gain 
decreased (linear, P = 0.001) with increasing SID lysine:ME ratio. The decreased costs were 
driven by the improvements in G:F. Income over feed cost increased (linear, P = 0.001) from 
$13.84/pig at 1.55 g SID lysine/Mcal ME to $17.94/pig at 2.55 g SID lysine/Mcal ME. The 
improvements in ADG and G:F with increasing SID dietary lysine both helped drive 
improvements in IOFC. In Exp. 3, optimal economic and growth responses occurred at the 
highest lysine level evaluated (2.55 g SID lysine/Mcal ME). Main et al. (2008) determined an 
optimal SID lysine:ME ratio of 1.90 g/Mcal for 100 to 120 kg gilts that were consuming 19.4 g 
of SID lysine per kilogram of BW gain. By estimating the amount of fat-free lean gain within the 
feeding period, Main et al. (2008) also predicted a similar requirement of 1.96 g SID lysine/Mcal 
ME. Friesen et al. (1995) observed optimal performance in 104 to 136 kg gilts when 2.16 g of 
AID lysine/Mcal ME was provided. On the basis of NRC digestibility coefficients, the optimal 
SID lysine:ME ratio observed by Friesen et al. (1995) would be 2.29g/Mcal. However, both 
starting and ending pig weights were heavier in both Main et al. (2008) and Friesen et al. (1995) 
than pigs in our study, which may explain the lower requirement. 
Advantages to increasing the SID lysine:ME ratio above that reported as optimal by Main 
et al. (2008) were observed in Exp. 1 and 3; however, the optimal SID lysine:ME ratio observed 
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in Exp. 2 was similar to current recommendations. One of the distinct differences between pigs 
in Exp. 1 and 3 and those in Exp. 2 was PRRSv status. Pigs in Exp. 1 and 3 were weaned without 
any evidence of PRRS infection, whereas those in Exp. 2 were PRRSv positive. Williams et al. 
(1997) showed that healthier pigs require increased dietary lysine because of increased potential 
for protein deposition compared with pigs with chronic immune stimulation. Klasing and Austic 
(1984) also showed an increase in skeletal muscle catabolism in broiler chicks that were injected 
with either sheep red blood cells or E. coli compared with chicks injected with saline. Immune 
responses alter the composition of growth because skeletal muscle accretion is reduced to a 
greater degree than visceral growth, resulting in lower yields of lean tissue (Klasing and Korver, 
1997). Therefore, pigs in Exp. 2 may have not responded to high dietary lysine levels because of 
decreased potential for protein deposition from the PRRSv infection.    
One possible explanation for the increase in response to higher levels of dietary lysine is 
vaccination against PCV2. Porcine circovirus type 2 vaccine has been shown to reduce mortality 
and improve overall performance of finishing pigs (Horlen et al., 2008, Jacela et al., 2008; Potter 
et al., 2008). As mentioned earlier, healthy pigs have increased daily dietary lysine needs 
because of increased lean tissue deposition; however, healthy pigs also have increased daily feed 
intake (Williams et al., 1997). The increased feed intake may or may not satisfy the pigs’ need 
for additional dietary lysine. The effect of PCV2 vaccination on the SID lysine:ME requirement 
should be evaluated to determine whether vaccinated pigs require more SID lysine/Mcal ME 
than non-vaccinates to meet their enhanced needs for protein deposition.  
Another explanation for the response to higher SID lysine:ME ratios may be that 
increased BW gain was not reflective of increased lean mass growth. Johnston et al. (2009) 
observed increases in growth and efficiency when feeding lysine levels greater than previously 
defined optimal levels; however, carcass yield was reduced with increasing lysine with no 
differences in primal cut weights. Johnston et al. (2009) concluded that whole-body growth from 
increasing dietary lysine did not translate into increased lean growth. 
Figure 1 depicts prediction equations for the ideal SID lysine:ME ratio obtained by 
plotting the optimal level in each of our 3 studies against the midpoint of BW. The ideal SID 
lysine:ME ratio was based on the ratio that generated the greatest level of IOFC. This equation, 
SID lysine:ME ratio = -0.011 × BW, kg + 3.617, estimates the optimal SID lysine:ME ratios for 
growth and economic performance for gilts (PIC 337 × 1050) in this commercial finishing 
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environment. Prediction equations for the optimum SID lysine:ME ratios from Main et al. (2008) 
and De La Llata et al. (2007) also were plotted to show any difference over time as each of these 
studies were conducted in the same facilities with similar genetic lines. The rate of change in the 
SID lysine:ME ratio as BW increases was reduced in our experiment compared with the two 
aforementioned studies.  
These trials indicated that optimal SID lysine:ME ratios for 38 to 65 kg gilts and 55 to 80 
kg gilts are 3.16 and 2.58g/Mcal, respectively, and that 84 to 100 kg gilts responded linearly 
through the highest level of 2.55 g/Mcal. Additional research is warranted to evaluate factors 
influencing the response to increased levels of dietary lysine fed to PRRSv-negative pigs that 
have also been vaccinated for PCV2. 
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Figures and Tables 
Table 1-1. Composition of diets, Exp. 1 (as-fed basis)
1
 
 SID
2
 lysine:ME, g/Mcal 
 2.01 2.30 2.58 2.87 3.16 3.45 
 SID lysine, % 
Item  0.70 0.80 0.90 1.00 1.10 1.20 
Ingredient, %       
Corn 79.40 75.42 71.45 67.47 63.50 59.52 
Soybean meal (46.5% CP) 15.49 19.47 23.44 27.42 31.39 35.37 
Choice white grease 3.00 3.00 3.00 3.00 3.00 3.00 
Monocalcium P (21% P) 0.50 0.50 0.50 0.50 0.50 0.50 
Limestone 0.90 0.90 0.90 0.90 0.90 0.90 
Salt 0.35 0.35 0.35 0.35 0.35 0.35 
Copper sulfate 0.03 0.03 0.03 0.03 0.03 0.03 
Vitamin premix
3
 0.08 0.08 0.08 0.08 0.08 0.08 
Trace mineral premix
4
 0.08 0.08 0.08 0.08 0.08 0.08 
L-Lys HCl 0.15 0.15 0.15 0.15 0.15 0.15 
Phytase
5
 0.02 0.02 0.02 0.02 0.02 0.02 
Total 100.00 100.00 100.00 100.00 100.00 100.00 
       
Calculated analysis       
SID amino acids, %       
Lys 0.7 0.8 0.9 1.0 1.1 1.2 
Ile:Lys 70 70 69 69 69 69 
Leu:Lys 175 165 157 151 146 141 
Met:Lys 31 29 28 27 26 26 
Met & Cys:Lys 64 60 58 56 54 53 
Thr:Lys 63 62 61 60 60 59 
Trp:Lys 19 19 19 19 20 20 
Val:Lys 83 81 79 78 77 76 
ME, kcal/kg 3,484 3,483 3,481 3,480 3,478 3,477 
Total lysine, % 0.79 0.90 1.01 1.12 1.23 1.34 
CP, % 14.1 15.6 17.1 18.6 20.1 21.7 
Ca, % 0.51 0.52 0.54 0.55 0.56 0.57 
P, % 0.43 0.45 0.47 0.48 0.50 0.52 
Available P, %
6
 0.24 0.24 0.25 0.25 0.26 0.26 
Diet cost, $/1000 kg
7
 256.28 263.80 271.31 278.82 286.33 293.85 
1
A total of 1,085 gilts (PIC 337 × 1050) were housed at approximately 27 pigs per pen and 7 replications per 
treatment in a 28-d trial. 
2
Standardized ileal digestible. 
3
Vitamin premix provided per kg of diet: 6,614 IU of vitamin A, 826.7 IU of vitamin D3, 26.46 IU of vitamin E, 2.65 
mg of vitamin k, 0.02 mg of vitamin B12, 29.76 mg of niacin, 16.53 mg of pantothenic acid, and 4.96 mg of 
riboflavin.  
4
Trace mineral premix provided per kg of diet: 13.23 mg Cu from Cu sulfate, 0.24 mg I from Ca iodate, 132.28 mg 
Fe from Fe sulfate, 31.75 mg Mn from Mn sulfate, 0.24 mg Se from Na selenite, and 132.28 mg Zn from Zn sulfate.   
5
Natuphos classic (BASF Corp.) provided (per kg of complete diet): 300 FTU of phytase. 
6
Phytase provided 0.08% available P to the diet. 
7
Diet costs were based on corn at $204.97/1000 kg and 46.5% soybean meal at $385.80/1000 kg. 
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Table 1-2. Composition of diets, Exp. 2 (as-fed basis)
1
 
  SID
2
 lysine:ME, g/Mcal 
  1.89 2.12 2.35 2.58 2.81 3.04 
  SID lysine, % 
Item             0.66 0.74 0.82 0.90 0.98 1.06 
Ingredient, %       
Corn 80.99 77.81 74.68 71.48 68.33 65.12 
Soybean meal (46.5% CP) 13.90 17.10 20.25 23.45 26.60 29.80 
Choice white grease 3.00 3.00 3.00 3.00 3.00 3.00 
Monocalcium P (21% P) 0.63 0.61 0.59 0.58 0.56 0.54 
Limestone 0.85 0.85 0.85 0.85 0.85 0.85 
Salt 0.35 0.35 0.35 0.35 0.35 0.35 
Vitamin premix
3
 0.05 0.05 0.05 0.05 0.05 0.05 
Trace mineral premix
4
 0.05 0.05 0.05 0.05 0.05 0.05 
L-Lys HCl 0.15 0.15 0.15 0.15 0.15 0.15 
DL-Met --- --- --- 0.005 0.015 0.035 
L-Thr ---- --- 0.005 0.010 0.015 0.025 
Phytase
5
 0.025 0.025 0.025 0.025 0.025 0.025 
Total 100.0 100.0 100.0 100.0 100.0 100.0 
        
Calculated analysis       
SID amino acids, %       
Lys 0.66 0.74 0.82 0.90 0.98 1.06 
Ile:Lys  70 70 70 69 69 69 
Leu:Lys 180 171 163 157 152 148 
Met:Lys 32 30 29 29 29 30 
Met & Cys:Lys  65 62 60 58 58 58 
Thr:Lys  63 62 62 62 62 62 
Trp:Lys  19 19 19 19 19 20 
Val:Lys  84 82 80 79 78 77 
ME, kcal/kg 3,485 3,484 3,484 3,483 3,483 3,483 
Total lysine, % 0.75 0.84 0.92 1.01 1.10 1.19 
CP, % 13.5 14.7 15.9 17.1 18.3 19.6 
Ca, % 0.51 0.52 0.52 0.53 0.54 0.54 
P, % 0.46 0.46 0.47 0.48 0.49 0.50 
Available P, %
6 
0.29 0.29 0.29 0.29 0.29 0.29 
Diet cost, $/1000 kg
7
 256.42 262.28 268.28 274.43 280.67 287.28 
1
A total of 1,092 gilts (PIC 337 × 1050) were housed at 26 pigs per pen and 7 replications per treatment in a 28-d 
trial. 
2
SID = standard ileal digestible. 
3
Vitamin premix provided per kg of diet: 4,409 IU of vitamin A, 551.2 IU of vitamin D3, 17.64 IU of vitamin E, 
1.76 mg of vitamin k, 0.02 mg of vitamin B12, 19.84 mg of niacin, 11.02 mg of pantothenic acid, and 3.31 mg of 
riboflavin.  
4
Trace mineral premix provided per kg of diet: 8.27 mg Cu from Cu sulfate, 0.15 mg I from Ca iodate, 82.67 mg 
Fe from Fe sulfate, 19.84 mg Mn from Mn sulfate, 0.15 mg Se from Na selenite, and 82.67 mg Zn from Zn sulfate.   
5
Optiphos 2000 (Enzyvia, Sheridan, IN) provided (per kg of complete diet): 500 FTU of phytase.  
6
Phytase provided 0.10% available P to the diet. 
7
Diet costs were based on corn at $204.97/1000 kg and 46.5% soybean meal at $385.80/1000 kg. 
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Table 1-3. Composition of diets, Exp. 3 (as-fed basis)
1
 
 SID
2
 lysine:ME, g/Mcal 
   1.55   1.75   1.95   2.15   2.35   2.55 
  SID lysine, % 
Item   0.54   0.61   0.68   0.75   0.82   0.89 
Ingredient, %       
Corn 85.84 83.07 80.30 77.54 74.76 72.00 
Soybean meal (46.5% CP)   9.12 11.91 14.69 17.47 20.25 23.03 
Choice white grease   3.00   3.00   3.00   3.00   3.00   3.00 
Monocalcium P (21% P)   0.58   0.56   0.55   0.53   0.52   0.50 
Limestone   0.85   0.85   0.85   0.85   0.85   0.85 
Salt   0.35   0.35   0.35   0.35   0.35   0.35 
Vitamin premix
3
   0.05   0.05   0.05   0.05   0.05   0.05 
Trace mineral premix
4
   0.05   0.05   0.05   0.05   0.05   0.05 
Lysine HCl   0.15   0.15   0.15   0.15   0.15   0.15 
L-Threonine      -      -      -      -     0.005   0.01 
Phytase
5
   0.01   0.01   0.01   0.01   0.01   0.01 
Total 100.00 100.00 100.00 100.00 100.00 100.00 
       
Calculated analysis       
SID amino acids, %       
Lys   0.54   0.61   0.68   0.75   0.82   0.89 
Ile:Lys   71   71   70   70   70   69 
Leu:Lys 200 188 178 170 164 158 
Met:Lys   35   33   31   30   29   28 
Met & Cys:Lys   71   68   64   62   60   58 
Thr:Lys   65   64   63   62   62   62 
Trp:Lys   18   18   19   19   19   19 
Val:Lys   88   85   83   82   80   79 
ME, kcal/kg  3,490 3,489  3,488  3,488 3,487  3,487 
Total lysine, %   0.62   0.69   0.77   0.85   0.92   1.00 
CP, % 11.70 12.70 13.80 14.90 15.90 17.00 
Ca, %   0.49   0.49   0.50   0.50   0.51   0.52 
P, %   0.42   0.43   0.44   0.45   0.46   0.47 
Available P, %
6
   0.22   0.22   0.22   0.22   0.22   0.22 
Diet cost, $/1000 kg
7
 243.07 248.21 253.37 258.52 263.80 269.08 
1
A total of 1,080 gilts (PIC 337 × 1050) were housed at approximately 27 pigs per pen and 7 replications per 
treatment in a 29-d trial. 
2
Standardized ileal digestible. 
3
Vitamin premix provided per kg of diet: 4,409 IU of vitamin A, 551.2 IU of vitamin D3, 17.64 IU of vitamin 
E, 1.76 mg of vitamin k, 0.02 mg of vitamin B12, 19.84 mg of niacin, 11.02 mg of pantothenic acid, and 3.31 
mg of riboflavin.  
4
Trace mineral premix provided per kg of diet: 8.27 mg Cu from Cu sulfate, 0.15 mg I from Ca iodate, 82.67 
mg Fe from Fe sulfate, 19.84 mg Mn from Mn sulfate, 0.15 mg Se from Na selenite, and 82.67 mg Zn from Zn 
sulfate.   
5
Optiphos 2000 (Enzyvia, Sheridan, IN) provided (per kg of complete diet): 200 FTU of phytase 
6
Phytase provided 0.05% available P to the diet. 
7
Diet costs were based on corn at $204.97/1000 kg and 46.5% soybean meal at $385.80/1000 kg.
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Table 1-4. Chemical composition of diets (Exp. 1)
1
 
 SID
2
 lysine:ME, g/Mcal 
 2.01 2.30 2.58 2.87 3.16 3.45 
  SID lysine, % 
Item, %
3
 0.70 0.80 0.90 1.00 1.10 1.20 
CP 13.6 (14.1) 14.6 (15.6) 16.1 (17.1) 16.8 (18.6) 19.1 (20.1) 19.4 (21.7) 
Lys 0.78 (0.79) 0.86 (0.90) 0.99 (1.01) 1.06 (1.12) 1.14 (1.23) 1.24 (1.34) 
Cys 0.22 (0.27) 0.24 (0.29) 0.27 (0.31) 0.27 (0.33) 0.30 (0.35) 0.31 (0.37) 
Ile 0.54 (0.56) 0.59 (0.63) 0.67 (0.71) 0.71 (0.78) 0.81 (0.86) 0.84 (0.93) 
Leu 1.31 (1.35) 1.36 (1.46) 1.48 (1.57) 1.54 (1.67) 1.68 (1.78) 1.74 (1.88) 
Met 0.22 (0.24) 0.23 (0.26) 0.25 (0.28) 0.28 (0.30) 0.27 (0.32) 0.29 (0.34) 
Met+Cys 0.45 (0.50) 0.47 (0.55) 0.52 (0.59) 0.55 (0.63) 0.57 (0.67) 0.60 (0.71) 
Thr 0.50 (0.52) 0.54 (0.58) 0.60 (0.64) 0.62 (0.70) 0.71 (0.76) 0.77 (0.83) 
Trp 0.14 (0.15) 0.15 (0.17) 0.18 (0.20) 0.20 (0.22) 0.22 (0.24) 0.23 (0.27) 
Val 0.63 (0.66) 0.68 (0.74) 0.76 (0.81) 0.80 (0.89) 0.87 (0.96) 0.91 (1.03) 
1
A total of 1,085 gilts (PIC 337 × 1050) were housed with approximately 27 pigs per pen and 7 replications per treatment in a 
28-d trial. 
2
Standardized ileal digestible. 
 
3
Analyzed values for protein and amino acids are shown and are based on a composite sample from 3 different collection 
times. Calculated values are shown in parentheses.  
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Table 1-5. Chemical composition of diets (Exp. 2)
1
 
 SID
2
 lysine:ME, g/Mcal 
 1.89 2.12 2.35 2.58 2.81 3.04 
  SID lysine, % 
Item, %
3
 0.66 0.74 0.82 0.90 0.98 1.06 
CP 14.4 (13.5) 14.3 (14.7) 15.9 (15.9) 16.6 (17.1) 17.68 (18.3) 18.3 (19.6) 
Lys 0.75 (0.75) 0.73 (0.84) 0.84 (0.92) 0.90 (1.01) 0.95 (1.10) 0.97 (1.19) 
Cys 0.20 (0.25) 0.20 (0.26) 0.22 (0.28) 0.24 (0.29) 0.25 (0.31) 0.25 (0.31) 
Ile 0.50 (0.53) 0.51 (0.59) 0.56 (0.65) 0.63 (0.71) 0.68 (0.77) 0.68 (0.83) 
Leu 1.22 (1.31) 1.21 (1.40) 1.28 (1.48) 1.40 (1.57) 1.46 (1.65) 1.44 (1.74) 
Met 0.26 (0.24) 0.25 (0.26) 0.27 (0.27) 0.29 (0.29) 0.30 (0.32) 0.32 (0.36) 
Met+Cys 0.47 (0.49) 0.46 (0.52) 0.49 (0.55) 0.53 (0.59) 0.55 (0.64) 0.56 (0.69) 
Thr 0.52 (0.49) 0.52 (0.54) 0.56 (0.60) 0.63 (0.65) 0.66 (0.71) 0.64 (0.77) 
Trp 0.14 (0.14) 0.14 (0.16) 0.15 (0.18) 0.17 (0.20) 0.18 (0.21) 0.19 (0.23) 
Val 0.59 (0.63) 0.59 (0.69) 0.65 (0.75) 0.72 (0.81) 0.76 (0.87) 0.75 (0.93) 
1
A total of 1,092 gilts (PIC 337 × 1050) were housed with approximately 26 pigs per pen and 7 replications per treatment in a 
28-d trial. 
2
Standardized ileal digestible.
 
3
Analyzed values for protein and amino acids are shown and are based on a composite sample from 3 different collection 
times. Calculated values are shown in parentheses. 
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Table 1-6. Chemical composition of diets (Exp. 3)
1
 
 SID
2
 lysine:ME, g/Mcal 
 1.55 1.75 1.95 2.15 2.35 2.55 
  SID lysine, % 
Item, %
3
 0.54 0.61 0.68 0.75 0.82 0.89 
CP 10.9 (11.7) 15.0 (12.7) 13.2 (13.8) 15.9 (14.9) 15.2 (15.9) 15.9 (17.0) 
Lys 0.62 (0.62) 0.92 (0.69) 0.79 (0.77) 0.99 (0.85) 0.93 (0.92) 1.07 (1.00) 
Cys 0.20 (0.23) 0.24 (0.25) 0.22 (0.26) 0.27 (0.28) 0.25 (0.29) 0.28 (0.31) 
Ile 0.42 (0.44) 0.59 (0.49) 0.54 (0.54) 0.65 (0.59) 0.63 (0.65) 0.71 (0.70) 
Leu 1.11 (1.18) 1.42 (1.26) 1.29 (1.33) 1.49 (1.41) 1.41 (1.48) 1.58 (1.56) 
Met 0.19 (0.21) 0.27 (0.22) 0.22 (0.23) 0.28 (0.25) 0.24 (0.26) 0.27 (0.28) 
Met+Cys 0.40 (0.44) 0.51 (0.47) 0.45 (0.50) 0.55 (0.53) 0.50 (0.55) 0.54 (0.58) 
Thr 0.42 (0.42) 0.60 (0.46) 0.51 (0.50) 0.64 (0.55) 0.58 (0.60) 0.64 (0.64) 
Trp 0.12 (0.11) 0.17 (0.13) 0.16 (0.14) 0.17 (0.16) 0.17 (0.18) 0.17 (0.19) 
Val 0.48 (0.54) 0.67 (0.59) 0.60 (0.65) 0.78 (0.70) 0.71 (0.75) 0.80 (0.80) 
1
A total of 1,080 gilts (PIC 337 × 1050) were housed with approximately 27 pigs per pen and 7 replications per treatment in a 
29-d trial.
 
2
Standardized ileal digestible.
 
3
Analyzed values for protein and amino acids are shown and are based on a composite sample from 3 different collection 
times. Calculated values are shown in parentheses. 
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Table 1-7. Effects of standardized ileal digestible (SID) lysine:ME ratio on growth and economic performance of 38 to 65 kg 
gilts (Exp. 1)
1
 
  SID lysine:ME, g/Mcal       
   2.01 2.30 2.58 2.87 3.16 3.45       
  SID lysine, %   Probability, P < 
 Item    0.7     0.8    0.9    1.0    1.1    1.2 SEM Linear Quadratic 
Initial weight, kg  38.2  38.1  38.2  38.3  38.3  38.2 0.99    0.94       0.98 
ADG, kg    0.82    0.87    0.93    0.95    0.97    0.97 0.011    0.001       0.003 
ADFI, kg    1.97    1.95    1.95    1.92    1.91    1.91 0.026    0.04       0.93 
G:F    0.42    0.45    0.48    0.49    0.51    0.51 0.003    0.001       0.001 
Final weight, kg  61.3  62.4  64.2  64.8  65.3  65.5 1.17    0.004       0.38 
Daily SID lysine intake, g  13.8  15.6  17.5  19.2  21.0  22.9 0.25    0.001       0.85 
SID lysine intake/kg gain, g  16.8  18.0  18.9  20.3  21. 8  23.5 0.13    0.001       0.001 
Feed cost/kg gain, $
2
    0.61    0.59    0.57    0.57    0.57    0.57 0.004    0.001       0.001 
IOFC, $/head
2,3
  16.35  17.72  19.50  20.02  20.39  20.39 0.257    0.001       0.001 
1
A total of 1,085 gilts (PIC 337 × 1050) were housed with approximately 27 pigs per pen and 7 replications per treatment in a 28-d 
trial. 
2
Feed costs were based on corn at $204.97/1000 kg and 46.5% soybean meal at $385.80/1000 kg.
 
3
Income over feed cost = value of gain at $132.28/100 kg live weight - feed costs during trial period.
 
18 
 
 
Table 1-8. Effects of standardized ileal digestible (SID) lysine:ME ratio on growth and economic performance of 55 to 80 
kg gilts (Exp. 2)
1
 
  SID lysine:ME, g/Mcal       
  1.89 2.12 2.35 2.58 2.81 3.04       
  SID lysine, %   Probability, P < 
 Item 0.66 0.74 0.82 0.90 0.98 1.06 SEM Linear Quadratic 
Initial weight, kg  55.2  55.2  55.2  55.2  55.2  55.2 1.07    0.99 0.98 
ADG, kg 0.90 0.89 0.95 0.97 0.98 0.96 0.015 0.001 0.12 
ADFI, kg 2.14 2.10 2.16 2.11 2.19 2.11 0.043    0.95 0.71 
G:F 0.42 0.42 0.44 0.46 0.45 0.46 0.008 0.001 0.32 
Final weight, kg  80.5   80.2  81.8  82.5  82.8  82.6 1.09    0.05 0.68 
Daily SID lysine intake, g  14.1  15.6  17.8  19.0  21.5  22.3 0.37 0.001 0.63 
SID lysine intake/kg gain, g  15.7  17.5  18.7  19.6  22.0  23.2 0.35 0.001 0.61 
Feed cost/kg gain, $
2
 0.61 0.62 0.61 0.59 0.62 0.62 0.011    0.67 0.34 
IOFC, $/head
2,3
  18.09  17.54  19.09  19.95  19.18  19.00 0.498    0.02 0.12 
1
A total of 1,092 gilts (PIC 337 × 1050) were housed with approximately 26 pigs per pen and 7 replications per treatment in a 28-d 
trial. 
2
Feed costs were based on corn at $204.97/1000 kg and 46.5% soybean meal at $385.80/1000 kg.
 
3
Income over feed cost = value of gain at $132.28/100 kg live weight - feed costs during trial period.
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Table 1-9. Effects of standardized ileal digestible (SID) lysine:ME ratio on growth and economic performance of 84 to 110 kg 
gilts (Exp. 3)
1
 
  SID lysine:ME, g/Mcal       
     1.55     1.75     1.95     2.15     2.35     2.55       
  SID lysine, %   Probability, P < 
 Item     0.54     0.61     0.68     0.75     0.82     0.89 SEM Linear Quadratic 
Initial weight, kg   84.2   84.1   84.2   84.1   84.1   84.1 1.27     0.98 0.98 
ADG, kg     0.83     0.87     0.87     0.93     0.95     0.98 0.014     0.001 0.90 
ADFI, kg     2.54     2.58     2.52     2.54     2.54     2.54 0.030     0.76 0.93 
G:F     0.33     0.34     0.35     0.37     0.37     0.39 0.004     0.001 0.95 
Final weight, kg 108.2 109.5 109.8 111.1 111.7 112.7 1.40     0.02 0.99 
Daily SID lysine intake, g   13.7   15.8   17.2   19.0   20.9   22.6 0.23     0.001 0.91 
SID lysine intake/kg gain, g   16.6   18.1   19.7   20.4   22.1   23.0 0.25     0.001 0.26 
Feed cost/kg gain, $
2
     0.75     0.74     0.73     0.71     0.71     0.70 0.009     0.001 0.87 
IOFC, $/head
2,3
   13.84   14.91   15.11   16.70   16.93   17.94 0.463     0.001 0.97 
1
A total of 1,080 gilts (PIC 337 × 1050) that were housed at approximately 27 pigs per pen and 7 replications per treatment in a 
29-d trial. 
2
Feed costs were based on corn at $204.97/1000 kg and 46.5% soybean meal at $385.80/1000 kg.
 
3
Income over feed cost = value of gain at $132.28/100 kg live weight - feed costs during trial period.
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Figure 1. Optimal SID lysine:ME ratio prediction equations were developed for PIC Line 337 gilts based on optimal growth 
performance. 
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CHAPTER 2 - Effects of porcine circovirus type 2 vaccine and 
increasing standardized ileal digestible lysine:ME ratio on growth 
performance and carcass composition of growing and finishing pigs 
housed in commercial facilities 
Abstract 
A series of 4 experiments were conducted to examine the effects of porcine circovirus 
type 2 (PCV2) vaccination on the response to increasing dietary lysine in growing and finishing 
pigs (PIC 337 × 1050). Vaccination treatments included PCV2 vaccinates (Circumvent PCV, 
Intervet Inc., Millsboro, DE) and non-vaccinates that were allotted at weaning. One half of the 
pigs were vaccinated on d 1 and 22 after weaning and all pigs were inoculated with serum 
containing porcine reproductive and respiratory virus (PRRSv) 30-d after weaning as part of this 
production system’s protocol. Experiments 1 and 2 evaluated 38 to 65 kg gilts and barrows, 
respectively, and Exp. 3 and 4 evaluated 100 to 120 kg gilts and barrows, respectively. 
Treatments were allotted in a completely randomized design into 2 × 4 factorials with 2 PCV2 
treatments (vaccinates and non-vaccinates) and 4 standardized ileal digestible (SID) lysine:ME 
ratios (2.24, 2.61, 2.99, and 3.36 g/Mcal in Exp. 1 and 2 and 1.49, 1.86, 2.23, and 2.61 g/Mcal in 
Exp. 3 and 4). There were 5 pens per treatment with 18 to 27 pigs per pen depending on the 
experiment. During the nursery period before  Exp. 1 and 2, the second PCV2 vaccination 
reduced (P < 0.04) ADG and ADFI in vaccinates compared with non-vaccinates. However, after 
pigs were inoculated with PRRSv, PCV2 vaccinates had improved (P < 0.001) G:F and a trend 
(P = 0.08) for improved ADG compared with non-vaccinates. At the start of Exp. 1 and 2, the 
number pigs per pen were greater (P < 0.001) in vaccinate pens due to  greater survival than 
non-vaccinates, and this increase was maintained throughout the experiments. No PCV2 
vaccination × SID lysine:ME ratio interactions were observed (P > 0.10) in any of the 4 studies. 
In Exp. 1 and 2, PCV2 vaccinates had increased (P < 0.001) ADG compared with non-
vaccinates.  The growth response was primarily due to increases in ADFI, suggesting a greater 
g/d lysine requirement for PCV2 vaccinates than non-vaccinates. In Exp. 1, increasing SID 
lysine:ME ratio increased (quadratic; P < 0.04) ADG and G:F up through 2.99 g/Mcal. In Exp. 
2, increasing the SID lysine:ME ratio improved (linear; P < 0.001) G:F. In Exp. 3, increasing the 
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SID lysine:ME ratio increased (quadratic; P < 0.05) ADG and G:F with improvements through 
1.86 g /Mcal. In Exp. 4, increasing the SID lysine:ME ratio increased ADG  (linear; P < 0.001) 
and G:F (quadratic; P = 0.03) . Although PCV2 vaccination improved growth, the corresponding 
increase in ADFI did not increase the SID lysine:ME ratio for growing and finishing barrows and 
gilts. 
Key words: growth, finishing pigs, lysine, porcine circovirus type 2 vaccine 
Introduction 
Porcine circovirus type 2 (PCV2) greatly increased in the U.S. pig population in the mid 
2000's and is characterized by increased mortality and decreased growth rate (Segalés et al., 
2006). As a result of porcine circovirus disease (PCVD), in some cases it was not uncommon to 
see growing-finishing pig mortality approach 20% (Horlen et al., 2007). Clinical signs of PCVD 
include but are not limited to enlarged lymph nodes, labored breathing, as well as poor body 
condition and muscle wasting (Harding et al., 1998; Sorden, 2000). Vaccination for PCV2 has 
been shown to increase growth rates and reduce mortality in growing and finishing pigs (Horlen 
et al., 2008, Jacela et al., 2008; Potter et al., 2008). With increased ADG and G:F of pigs 
vaccinated for PCV2 compared with those not vaccinated, it might be speculated that dietary 
amino acid needs may be increased as well.  Williams et al. (1997a; b) observed increased lysine 
requirement estimates in pigs with low immune system activity. This was speculated to be a 
result of increased lean tissue deposition in pigs with low immune system activity compared with 
pigs under a greater health challenge.   
Lysine requirement estimates have been modeled and calculated (Cromwell et al., 1993; 
NRC 1998; Cline et al. 2000; Main et al. 2008); however, recent studies by Shelton et al. (2008; 
2009) have found improvements in growth and efficiency to feeding higher dietary lysine levels 
than these earlier estimates published by Main et al. (2008). Therefore, along with the 
advancement in genetic lines, the increase in health status and growth rate due to the PCV2 
vaccination may be one of the main factors driving an increase in lysine requirements observed 
by Shelton et al. (2008; 2009). Therefore, the objective of these experiments was to evaluate the 
effects of PCV2 vaccination on pig performance and determine whether it influences the dietary 
lysine requirement. 
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Materials and Methods 
General 
Procedures in this experiment were approved by the Kansas State University Institutional 
Animal Care and Use Committee. The experiment was conducted at commercial research 
finishing facilities in southwestern Minnesota. These facilities were double curtain sided with 
completely slatted flooring. Each of the 4 research barns contain 48 pens (3.05 × 5.49 m) with 
each pen containing a 5-hole conventional dry feeder (STACO, Inc., Schaefferstown, PA) and a 
cup waterer to allow ad libitum consumption of feed and water. An automated feeding system 
(FeedPro
TM
; Feedlogic Corp., Willmar, MN) was used to deliver and recording feed amounts on 
an individual pen basis. 
Allotment and Application of Porcine Circovirus Type 2 Vaccine 
For all experiments, a total of 2,571 barrows and gilts (PIC 337 × 1050; Hendersonville, 
TN: initially 5.7 kg) were weaned into 1 of the research finisher barns. Pens were double stocked 
with 56 pigs per pen, and gilts and barrows were penned separately. A total of 46 pens were 
used; 24 pens contained barrows, and 22 pens contained gilts. Industry standard nursery diets 
were budgeted and fed to all pigs during this phase that met or exceeded all nutrient requirements 
as outlined by the NRC (1998). All pigs were vaccinated for M. hyopneumoniae while in the 
farrowing facility. The PCV2 vaccination treatments were allotted by pen at placement to both 
barrow and gilt pens in a completely randomized design within gender. The number of 
vaccinated and unvaccinated pigs was equal within gender.  Vaccine treatments included either 
no PCV2 vaccine or vaccination with 2 doses of commercial PCV2 vaccine (Circumvent PCV, 
Intervet Inc., Millsboro, DE) given according to label directions on d 1 and 22 after weaning. As 
part of this farm’s standard production protocol, all pigs were then injected with serum 
containing porcine reproductive and respiratory virus (PRRSv) on d 30 after weaning. Briefly, 
serum which had been derived from a PRRSv infected pig and PRRSv viral particle quantity 
estimated using PCR was diluted 1:1,000 with sterile water and administered to pigs IM. Further 
analysis with real time PCR found the serum contained 1.7 × 10
3
 viral copies per reaction.   
Pig weights (by pen) and feed disappearance were measured in approximately 14-d 
intervals throughout the nursery period. On the basis of these measurements, ADG, ADFI, and 
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G:F were calculated for each pen. On d 51, the original pens of barrows or gilts, which were 
double stocked at 56 pigs per pen, were split to form 2 new pens of pigs of 22 to 27 pigs per pen, 
depending on the number of pigs remaining. All gilts were moved to an adjacent barn of similar 
design, with barrows remaining in the original site. The proportion of pigs throughout the pre-
test and experimental periods was also determined to observe any differences in removal and 
mortality between vaccine treatments. 
Finishing Period 
For Exp. 1 and 2, a total of 1,008 gilts (initially 38.3 kg) and 1,002 barrows (initially 
38.9) were selected and used in 28-d trials. Four experimental diets were used in Exp. 1 and 2 
with standardized ileal digestible (SID) lysine:ME ratios of 2.24, 2.61, 2.99, and 3.36 g/Mcal, 
which correspond to SID concentrations of 0.78, 0.91, 1.04, and 1.17 % or total lysine 
concentrations of 0.88, 1.02, 1.17, and 1.31 % (Table 1). Standard ileal digestible amino acid 
values from the NRC (1998) were used in diet formulation. Diets were corn-soybean meal-based 
with 0.15% added L-lysine HCl. Corn and soybean meal concentrations were changed to achieve 
the desired SID lysine:ME ratio in the diet. In addition, all diets contained 3% added fat from 
choice white grease. Diets were formulated to meet all other requirements recommended by 
NRC (1998). Test diets were sampled in each experiment, and a subsample of each diet was 
analyzed for amino acid concentrations (Table 2 and 3, for Exp. 1 and 2, respectively). Amino 
acid analysis was performed by Ajinimoto Heartland LLC (Chicago, IL) by HPLC (AOAC, 
2000). After the conclusion of Exp. 1 and 2, all pigs were placed on diets that contained at least 
2.58 g SID lysine/Mcal ME. Before beginning Exp. 3 and 4, some pigs were removed from each 
pen, with more pigs removed from vaccinated pens to attempt to minimize the difference in pig 
density and initial weight between the PCV2 vaccinates and non-vaccinates.  
A total of 930 gilts (initially 101.8 kg) and 825 barrows (initially 97.7 kg) were then used 
in Exp. 3 and 4 for 28 and 21 d, respectively. Four experimental diets were again used with SID 
lysine:ME ratios of 1.49, 1.86, 2.23, and 2.61 g/Mcal, which correspond to dietary SID lysine 
concentrations  of 0.52, 0.65, 0.78, and 0.91 % or total lysine concentrations of 0.59, 0.74, 0.88, 
and 1.02 % (Table 4). Similar to Exp. 1 and 2, diets were corn-soybean meal-based with 0.15% 
added L-lysine HCl and 3% added fat from choice white grease. Diet samples were collected 
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from each diet in each experiment and analyzed for amino acid concentrations (Table 5 and 6 for 
Exp. 3 and 4, respectively).   
For each experiment, dietary treatments were allotted within PCV2-vaccinated and non-
vaccinated pens in a completely randomized design. Each experiment had 5 replications for each 
diet and vaccine treatment combination. Pen densities varied from 18 to 27 pigs per pen 
depending on the experiment. 
Pig weights (by pen) and feed disappearance were measured throughout the experiments. 
On the basis of these measurements, ADG, ADFI, G:F, daily SID lysine intake, and SID lysine 
intake per kg BW gain were calculated for each pen. At the conclusion of the growth portion of 
Exp. 3 and 4, the pigs were marketed to a USDA-inspected packing plant (JBS Swift & 
Company processing plant, Worthington, MN) and carcass data was collected. Pen data for yield, 
backfat depth, loin depth, percentage lean, fat-free lean index, and live value were determined by 
the packing plant. Yield reflects the percentage of HCW relative to live weight (obtained at the 
packing plant).  
Statistical Analysis  
Data from the nursery pre-test period was analyzed as a 2 × 2 factorial (gender and PCV2 
vaccination status). Both vaccine treatment and gender were treated as fixed effects in the model. 
The nursery growth and finishing weight responses were analyzed using the PROC MIXED 
procedure in SAS (SAS Institute Inc., Cary, NC). The percentage of remaining pigs was 
analyzed using the PROC GENMOD procedure in SAS utilizing a Poisson distribution. The 
original pen was used as the experimental unit in all these analyses.  
Data from Exp. 1, 2, 3, and 4 were analyzed as a completely randomized design with 
treatments arranged as a 2 × 4 factorial in a split plot for each experiment. The 2 PCV2 vaccine 
treatments were applied on the whole plot and the 4 dietary lysine concentrations served as the 
split plot treatment factor. The denominator degrees of freedom were calculated using the 
Kenward-Roger correction. Vaccine treatments and dietary lysine concentrations were treated as 
fixed effects for analysis. Growth and carcass data were analyzed using the MIXED procedure in 
SAS, and pen counts were analyzed using the GENMOD procedure in SAS. Dietary lysine 
values were used as dose levels to test for linear and quadratic responses to dietary treatments. 
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Pen was used as the experimental unit in all analyses. Effects were considered significant if their 
P-values were < 0.05 and trends if their P-values were < 0.10. 
Results 
For each experiment, the analyzed concentrations of amino acids for the feed samples 
collected were similar to the calculated total values (within the acceptable limits for analytical 
variation).  
The nursery pre-trial performance is shown in Table 7. From d 0 to 15, no difference in 
ADG, ADFI, or G:F was observed (P > 0.10) between vaccinates and non-vaccinates, indicating 
that the first injection of PCV2 vaccine did not affect performance. However, in the period after 
the second injection (d 15 to 29), PCV2-vaccinated pigs had decreased (P = 0.02) ADG 
compared with non-vaccinates; which appears to be a result of decreased (P = 0.04) ADFI. Gilts 
had greater (P < 0.04) ADG and ADFI than barrows. A trend was also observed (P = 0.07) for a 
gender × vaccine interaction for G:F from d 15 to 29. This interaction was due to a slight 
improvement in G:F in vaccinated barrows and a slight decrease in G:F in vaccinated gilts 
compared to unvaccinated gilts. In the period after inoculation with PRRSv (d 29 to 50), PCV2 
vaccinates had improved (P = 0.001) G:F and a trend for increased (P = 0.08) ADG compared 
with non-vaccinates. Gilts also had poorer (P < 0.005) G:F compared with barrows from d 29 to 
50. Over the entire 50-d nursery period, no differences were observed (P > 0.10) for ADG, 
ADFI, or final weight between gender or between PCV2 vaccinates and non-vaccinates. 
However, G:F was improved (P = 0.001) with PCV2 vaccination and improved (P < 0.03) for 
barrows compared with gilts. Also, no differences were observed (P > 0.10) in the percentage of 
pigs remaining in pens throughout the nursery portion of the study (d 15, 29, or 50; Table 8). 
For each of the 4 experiments, no PCV2 vaccine × lysine interactions were observed (P > 
0.10) for any of the growth or carcass criteria (Tables 9, 10, 11, and 12). In Exp. 1 (38 to 60 kg 
gilts), PCV2-vaccinated pigs tended (P = 0.08) to be heavier (1.6 kg) at initiation of the trial (d 
0) and had an increased (P = 0.001) number of pigs per pen (3.6 pigs more per pen) compared 
with non-vaccinates (Table 9). This initial difference was due to the increase in removals and 
decrease in pre-trial performance of pigs in non-vaccinated pens. Vaccinated pigs had increased 
(P < 0.001) ADG, final weight, and daily SID lysine intake, and tended to have increased (P = 
0.10) G:F compared with non-vaccinates. The increased growth for PCV2 vaccinates was 
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primarily driven by increased (P = 0.001) ADFI compared with non-vaccinates. In addition, at 
the conclusion of the experiment, pens of pigs vaccinated with PCV2 vaccine maintained a 
greater (P = 0.001) pen head count (5.0 more pigs per pen) than non-vaccinates. Average daily 
gain and G:F improved (quadratic; P < 0.04) as the SID lysine:ME ratio increased through 2.99 
g/Mcal. Feed intake tended to decrease (linear; P = 0.06) as the SID lysine:ME increased. 
Increasing dietary lysine also increased (linear; P < 0.001) daily lysine intake and SID lysine/kg 
gain. The optimal SID lysine:ME ratio for 38 to 60 kg gilts was 2.99 g/Mcal where both PCV2 
vaccinated and non-vaccinated gilts consumed 21.5 g SID lysine/kg gain.  
In Exp. 2 (39 to 65 kg barrows), similar to the gilts in Exp. 1, PCV2 vaccinates tended to 
be heavier (P = 0.06) at the start of the experiment and had increased (P = 0.001) initial pen 
head count (4.4 more pigs per pen) compared with non-vaccinates (Table 10). Vaccination for 
PCV2 also increased (P < 0.04) ADG, final weight, and daily lysine intake and tended to 
improve (P = 0.10) G:F. Similar to Exp.1 the increased growth in PCV2 vaccinated pigs 
compared with non-vaccinates was driven primarily by increased (P = 0.001) ADFI. At the 
conclusion of Exp. 2, pen head counts were greater (P = 0.001) for PCV2-vaccinated pens than 
for non-vaccinated pens by 7 pigs. Increasing SID lysine:ME ratio had no effect (P > 0.10) on 
ADG, but increased (linear; P < 0.001) G:F, daily SID lysine intake, and SID lysine intake/kg 
gain. However similar to Exp. 1, ADFI tended to decrease (linear; P = 0.07) as dietary lysine 
increased. Optimal performance for 39 to 65 kg barrows was observed at the highest level of 
3.36 g SID lysine/Mcal ME where barrows consumed 25.0 g SID lysine/kg gain.  
In Exp. 3 (102 to 125 kg gilts), PCV2-vaccinated pigs had increased (P < 0.002) starting 
weight and 2 more pigs per pen than non-vaccinates. The smaller difference in pigs per pen was 
a result of removing more pigs from PCV2 vaccinated than non-vaccinated pens at initial barn 
marketing, which began just before the start of Exp. 3 and 4 (Table 11). No differences in ADG 
or ADFI were detected (P > 0.10) between PCV2 vaccinates and non-vaccinates. However, 
PCV2 vaccinates had increased (P < 0.03) G:F, final weight, final head count, SID lysine 
intake/kg gain, and backfat thickness. Both ADG and G:F improved (quadratic; P < 0.05) as the 
SID lysine:ME ratio increased, with ADG improving through 1.86 g/Mcal and G:F improving 
through 2.23 g/Mcal. Feed intake tended to decrease (linear; P = 0.09) as dietary lysine 
increased. But despite the decreases in feed intake, daily SID lysine intake and SID lysine 
intake/kg gain increased (linear; P < 0.001) with increasing  dietary lysine. No dietary lysine 
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effects were observed (P > 0.10) for any of the carcass criteria. Based on improvement in G:F, 
the optimal SID lysine:ME ratio for 102 to 125 kg gilts  appeared to be  2.23 g/Mcal, with gilts 
consuming 24.1 g SID lysine/kg gain.  
In Exp. 4 (98 to 118kg barrows), there was a difference (P = 0.001) in the initial average 
pen head count, with vaccinate pens having almost 3 more pigs per pen than non-vaccinated pens 
(Table 12). However, there was no difference (P = 0.10) in starting weight between vaccination 
treatments. Both ADG and ADFI were decreased (P < 0.04) in vaccinated pens compared with 
non-vaccinated pens, and the average pen head count was greater (P = 0.001) at the conclusion 
of the trial for vaccinated pens. In this study, ADG, G:F, daily SID lysine intake, and SID lysine 
intake/kg gain increased (linear; P < 0.001) through the greatest SID lysine:ME ratio of 2.61 
g/Mcal, with the greatest change occurring when the ratio increased from 2.23 to 2.61 g/Mcal. 
Increasing dietary lysine tended to first increase and then decrease (quadratic; P = 0.06) ADFI. 
Similar to Exp. 3, no differences in any carcass characteristics were observed (P > 0.10) as the 
SID lysine:ME ratio increased. Therefore, the optimal SID lysine:ME ratio in this study was 2.61 
g/Mcal for 97 to 118 kg barrows consuming 27.3 g SID lysine/kg gain. 
Discussion  
Porcine circovirus type 2 is one of the main causative agents for PCVD, which can be  
characterized by chronic muscle wasting and lymph node enlargement as a result of postweaning 
multisystemic wasting syndrome (Horlen et al., 2007). It greatly increased in the U.S. pig 
population in the mid 2000's and is characterized by increased mortality and decreased growth 
rate (Horlen et al., 2008). One theory is that PCV2 weakens the pig's immune system and 
predisposes the pigs to additional infections. This is supported by Kixmoller et al. (2008) who 
observed lower quantities of coinfecting agents in pigs vaccinated against PCV2 compared with 
non-vaccinated counterparts. Vaccination for PCV2 has been shown to reduce mortality and 
increase growth performance (Horlen et al., 2008, Jacela et al., 2008; Potter et al., 2008). Results 
of our trials demonstrate the same benefit of reduced mortality and increased growth rate with 
the greatest impact in the early finisher phase and after the challenge of PRRS inoculation. These 
results are consistent with Oppriessnig et al. (2004) who demonstrated that cofactors, such as 
PRRS, increase the severity of PCVD.  
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Our data also agrees with Kane et al. (2009) and Potter et al. (2009) that demonstrated 
that the PCV2 vaccine used in these experiments reduces nursery performance, but increases 
finisher performance. The reduced nursery growth performance appears to be due from 
decreased feed intake after vaccination. The second injection in a 2-dose program seems to 
decrease feed intake to a greater degree, compared to the initial injection (Potter et al., 2009). 
The use of PCV2 vaccine created an excellent model to demonstrate differences in pig 
performance due to an immune challenge in Exp. 1 and 2. Results from Exp. 1 indicate that 38 to 
60 kg gilts required 2.99 g SID lysine/Mcal ME for maximal performance, while in Exp. 2, 39 to 
65 kg barrows showed a linear response to increasing SID lysine:ME ratio on G:F through 3.36 g 
SID lysine/Mcal ME. Shelton et al. (2008) observed similar improvements in growth and feed 
efficiency for 38 to 65 kg gilts up to 3.16 g SID lysine/Mcal ME. Main et al. (2008) observed 
increases in gain and efficiency through only 2.84 g SID lysine/Mcal ME  for 35 to 60 kg gilts  
and 43 to 70 kg barrows. Our study was conducted in the same facilities with the same genetic 
lines as those in Main et al. (2008) and Shelton et al. (2008). Our studies showed similar 
responses to higher SID lysine:ME ratios as those observed by Shelton et al. (2008) and slightly 
higher responses than Main et al. (2008). Results indicated that the lower growth performance 
from the immune challenge decreased the lysine requirement when expressed on a g/d basis; but 
not when expressed relative to the energy level of the diet (g/Mcal ME), relative to the weight 
gain of the pigs (g/kg of gain), or as a percentage of the diet.  
Health status has been shown to affect the lysine requirement estimate of weanling and 
finishing pigs (Williams et al., 1997a, b). Williams et al. (1997a, b) observed increased lysine 
requirements in pigs with low immune system stimulation and attributed the cause to increased 
lysine needs to accommodate increased protein deposition. This suggests that healthy pigs may 
require a greater concentration of dietary lysine than health challenged pigs. Williams’ et al. 
(1997a, b ) data confirmed the findings of Klasing and Austic (1984). They observed increased 
skeletal muscle break down in broiler chicks with high the immune system stimulation by 
injection of either E. coli or sheep red blood cells, suggesting the animals with less immune 
system activity will have greater rate of protein deposition. This suggests that healthy animals 
may require a greater dietary lysine concentration due to decreased protein accretion compared 
with animals with high immune activation. Our study showed no difference in response to 
increasing the SID lysine:ME ratio in PCV2 vaccinates compared with non-vaccinates. Despite 
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this, PCV2 vaccinates had increased ADFI in Exp. 1 and 2 compared with non-vaccinates, 
suggesting that within that stage of growth, PCV2 vaccinates would have an increased daily 
lysine requirement to accommodate for greater protein deposition rates.  
Experiments 1 and 2 showed increased performance in PCV2 vaccinates as compared to 
non-vaccinates, however that growth advantage was not observed in Exp. 3 or 4. Pens vaccinated 
for PCV2 had higher pen counts (up to 5 pigs per pen) in each of the 4 experiments than non-
vaccinated pens. The difference in pig density may have limited the improvements in growth for 
PCV2 vaccinates due to pig spatial and feeder space limitations.  Limited research has been done 
to estimate feeder trough space requirements for growing and finishing pigs. Throughout these 4 
experiments, feeder trough space ranged from 5.4 to 8.4 cm per pig. Feeder space 
recommendations range from 2.5 (Farrin, 1990) to 7.4 cm feeder trough space for a 100 kg pig 
(English et al., 1988). In addition, studies have also shown that pigs will alter their behavior 
when feeder space is decreased to compensate and render growth performance unaffected (Hyun 
and Ellis, 2002). Therefore, feeder space was likely not a limiting factor. Based on equations 
from Gonyou et al. (2006), pig space would not have been limiting in Exp. 1 and 2 between 
vaccinated and non-vaccinated pens as pens had not reached the critical k-value of 0.0336 (k = 
(BW
0.667
)/(floor space per pig)) at which space becomes a liming factor for growth rate despite 
the differences in number of pigs per pen. In Exp. 3 and 4, pig space may have been a 
confounding factor as PCV2 vaccinated pens would have reached the k-value during the early 
portion of the Exp. 3 and 4, while non-vaccinated pens would reach the critical limit at a later 
time in trial. This in mind, Jacela (2009) showed that the improved growth from PCV2 
vaccination is primarily observed early in the finishing stage, and therefore we would not 
anticipate any performance differences between vaccine treatments in Exp. 3 and 4.  
In Exp. 3, performance was maximized in 102 to 125 kg gilts when 2.23 g SID lysine/ 
Mcal ME was fed. Main et al. (2008) determined an optimal SID lysine:ME ratio 1.90 g/Mcal. 
Friesen et al. (1995) observed optimal performance in 104 to 136 kg gilts when 2.16 g of AID 
lysine/Mcal ME was provided. By utilizing the NRC conversion factors, the optimal SID 
lysine:ME ratio observed by Friesen et al. (1995) would be similar at 2.29 g/Mcal. Shelton et al. 
(2008) observed linear improvements in ADG and G:F through 2.55 g SID lysine/Mcal ME for 
85 to 110 kg gilts. The greater requirement estimate observed by Shelton et al (2008) may be due 
to the lower BW, but is still greater than the requirement estimate from previous trials.  
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Performance in Exp. 4 was maximized at the highest SID lysine:ME ratio of 2.61 g/Mcal 
for 97 to 118 kg barrow consuming 27.3 g SID lysine/kg BW gain. This response was similar to 
that of Shelton et al. (2008) for 85 to 110 kg gilts where performance increased linearly through 
the highest level of 2.55 g SID lysine/Mcal ME with gilts consuming 23.0 g of SID lysine/kg 
BW gain. However, Main et al. (2008) observed a much lower optimal SID lysine:ME ratio of 
1.90 g SID lysine/Mcal ME for 102 to 120 kg barrows.  
No significant  responses were detected to increasing SID lysine:ME ratio on carcass 
measurements in either Exp. 3 or 4. We would anticipate an increase in lean composition of the 
carcass as the SID lysine:ME ratio was increased to the requirement due to increased protein 
accretion (Cromwell et al., 1993; Hahn et al., 1995; De La Llata et al., 2007). Johnston et al. 
(2009) concluded that increases in whole body growth from increasing the lysine curve above the 
genetic supplier's recommendations (PIC. 2008) may not be reflective of carcass growth, and 
increases in dietary lysine may be negatively correlated with carcass yield. Our two studies did 
not observe any difference in yield with increasing dietary lysine, and observed no advantage in 
backfat reduction or loin depth with increasing the SID lysine:ME ratio.  
In conclusion, this study has shown similar advantages to increasing the SID lysine:ME 
ratio as Shelton et al. (2008; 2009), which are greater in magnitude than those previously 
reported in the same facility by Main et al. (2008). No differences in the optimal SID lysine:ME 
ratio were observed between PCV2 vaccinates and non-vaccinates; however, the increased 
growth from increased ADFI in Exp. 1 and 2 would suggest that PCV2 vaccinates have increased 
daily lysine requirements on a g/d basis compared with non-vaccinates from 40 to 60 kg.  
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Figures and Tables 
Table 2-1. Composition of diets, Exp. 1
1
 and 2
2
 (as-fed basis) 
 
SID
3
 lysine:ME, g/Mcal 
 
2.24 2.61 2.99 3.36 
 
SID lysine, % 
Item 0.78 0.91 1.04 1.17 
Ingredient, % 
    
Corn 75.52 70.16 64.81 59.44 
Soybean meal (45% CP) 19.38 24.74 30.09 35.45 
Choice white grease 3.00 3.00 3.00 3.00 
Monocalcium P (21% P) 0.54 0.51 0.48 0.45 
Limestone 0.90 0.90 0.90 0.90 
Salt 0.35 0.35 0.35 0.35 
L-Thr 0.005 0.015 0.020 0.030 
Met hydroxy analog --- 0.015 0.045 0.070 
Vitamin and trace mineral premix
4
 0.10 0.10 0.10 0.10 
Phytase
5
 0.013 0.013 0.013 0.013 
Liquid Lys (60% Lys) 0.195 0.195 0.195 0.195 
Total 100.00 100.00 100.00 100.00 
     Calculated analysis 
    SID amino acids, % 
    Lys 0.78  0.91  1.04  1.17  
Ile:Lys 70 69 69 69 
Leu:Lys 167 156 148 142 
Met:Lys 29 29 30 31 
Met & Cys:Lys 61 59 58 58 
Thr:Lys 62 62 62 62 
Trp:Lys 19 19 20 20 
Val:Lys 81 79 77 76 
ME, kcal/kg 3,483 3,483 3,481 3,481 
Total Lys, % 0.88  1.02  1.17  1.31 
CP, % 15.4 17.5 19.5 21.6 
Ca, % 0.53 0.54 0.56 0.57 
P, % 0.46 0.47 0.49 0.51 
Available P, %
6
 0.27 0.27 0.27 0.27 
1
A total of 1,008 gilts (PIC 337 × 1050) were used in this 28-d trial with 5 replications per PCV2 
vaccination and diet combination. 
2
A total of 1,002 barrows (PIC 337 × 1050) were used in this 28-d trial with 5 replications per 
PCV2 vaccination and diet combination. 
3
Standardized ileal digestible. 
4
Vitamin and trace mineral premix provided per kg of diet: 4,509 IU of vitamin A, 701.5 IU of 
vitamin D3, 24.05 IU of vitamin E, 1.40 mg of vitamin K, 3.01 mg of Riboflavin, 15.03 mg of 
vitamin B12, 18.04 mg of Niacin, 12.03 mg of pantothenic acid, 40.08 mg of Mn from Mn oxide, 
100.21 mg Zn from Zn sulfate, 90.19 mg Fe from Fe sulfate, 10.02 mg Cu from Cu sulfate, 0.30 
mg of Se from Na selenite, and 0.50 mg of I from EDDI.  
5
OptiPhos 2000 (Enzyvia; Sheridan, IN) provided (per kg of complete diet) 500 FTU of phytase.
 
6
Phytase provided 0.10% available P to the diet. 
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Table 2-2. Chemical composition of diets (Exp. 1)
1
 
 
SID
2
 lysine:ME, g/Mcal 
 
2.24 2.61 2.99 3.36 
 
SID lysine, % 
 Item, % 0.78 0.91 1.04 1.17 
CP 13.8 (15.4)
3
 15.4 (17.5) 17.4 (19.5) 19.3 (21.6) 
Essential amino acids 
    Arg 0.88 1.03 1.17 1.34 
His 0.38 0.42 0.47 0.53 
Ile 0.60 (0.62) 0.69 (0.71) 0.78 (0.81) 0.88 (0.91) 
Leu 1.28 (1.43) 1.43 (1.57) 1.58 (1.71) 1.72 (1.84) 
Lys 0.86 (0.88) 0.99 (1.02) 1.11 (1.17) 1.27 (1.31) 
Met 0.25 (0.25) 0.28 (0.29) 0.30 (0.34) 0.33 (0.39) 
Met + Cys 0.48 (0.54) 0.53 (0.60) 0.58 (0.68) 0.64 (0.76) 
Phe 0.75 0.85 0.95 1.06 
Thr 0.57 (0.57) 0.63 (0.66) 0.71 (0.75) 0.81 (0.84) 
Trp 0.16 (0.17) 0.18 (0.20) 0.22 (0.23) 0.24 (0.26) 
Val 0.65 (0.72) 0.74 (0.82) 0.83 (0.91) 0.94 (1.01) 
Nonessential amino acids 
    Ala 0.76 0.83 0.91 0.99 
Asp 1.39 1.63 1.85 2.14 
Cys 0.23 0.25 0.28 0.31 
Glu 2.47 2.81 3.15 3.54 
Gly 0.57 0.65 0.73 0.84 
Pro 0.83 0.88 0.93 1.00 
Ser 0.70 0.79 0.89 1.00 
Tyr 0.41 0.48 0.52 0.61 
1
A total of 1,008 gilts (PIC 337 × 1050) were used in this 28-d trial with 5 replications per 
PCV2 vaccination and diet combination. 
2
Standardized ileal digestible.  
3
Values in parentheses indicate formulated values.  
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Table 2-3. Chemical composition of diets (Exp. 2)
1
 
 
SID
2
 lysine:ME, g/Mcal 
 
2.24 2.61 2.99 3.36 
 
SID lysine, % 
Item, % 0.78 0.91 1.04 1.17 
CP 13.6 (15.4)
3
 15.1 (17.5) 17.3 (19.5) 19.1 (21.6) 
Essential amino acids 
    Arg 0.86 0.99 1.17 1.29 
His 0.38 0.42 0.48 0.52 
Ile 0.57 (0.62) 0.66 (0.71) 0.75 (0.81) 0.81 (0.91) 
Leu 1.28 (1.43) 1.38 (1.57) 1.54 (1.71) 1.65 (1.84) 
Lys 0.85 (0.88) 0.96 (1.02) 1.12 (1.17) 1.23 (1.31) 
Met 0.25 (0.25) 0.27 0.29) 0.30 (0.34) 0.33 (0.39) 
Met + Cys 0.48 (0.54) 0.52 (0.60) 0.58 (0.68) 0.63 (0.76) 
Phe 0.76 0.83 0.94 1.04 
Thr 0.56 (0.57) 0.62 (0.66) 0.71 (0.75) 0.78 (0.84) 
Trp 0.15 (0.17) 0.17 (0.20) 0.21 (0.23) 0.20 (0.26) 
Val 0.65 (0.72) 0.72 (0.82) 0.83 (0.91) 0.91 (1.01) 
Nonessential amino acids 
    Ala 0.78 0.82 0.90 0.99 
Asp 1.39 1.58 1.85 2.04 
Cys 0.23 0.25 0.28 0.30 
Glu 2.48 2.74 3.13 3.43 
Gly 0.58 0.64 0.73 0.82 
Pro 0.97 1.01 1.04 1.19 
Ser 0.70 0.77 0.89 0.97 
Tyr 0.42 0.47 0.51 0.56 
1
A total of 1,002 barrows (PIC 337 × 1050) were used in this 28-d trial with 5 replications per 
PCV2 vaccination and diet combination. 
2
Standardized ileal digestible.  
3
Values in parentheses indicate formulated values. 
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Table 2-4. Composition of diets, Exp. 3
1
 and 4
2
 (as-fed basis) 
 
SID
3
 lysine:ME, g/Mcal 
 
1.49 1.86 2.23 2.61 
 
SID lysine, % 
Item 0.52 0.65 0.78 0.91 
Ingredient, % 
    
Corn 86.46 81.12 75.77 70.41 
Soybean meal (45% CP) 8.66 14.01 19.36 24.72 
Choice white grease 3.00 3.00 3.00 3.00 
Monocalcium P (21% P) 0.40 0.38 0.35 0.32 
Limestone 0.85 0.85 0.85 0.85 
Salt 0.35 0.35 0.35 0.35 
L-Thr --- 0.01 0.02 0.035 
Met hydroxy analog --- --- 0.005 0.025 
Vitamin and trace mineral premix
4
 0.08 0.08 0.08 0.08 
Phytase
5
 0.013 0.013 0.013 0.013 
Liquid Lys (60% Lys) 0.195 0.195 0.195 0.195 
Total 100.00 100.00 100.00 100.00 
     Calculated analysis 
    SID amino acids, % 
    Lys 0.52 0.65 0.78 0.91 
Ile:Lys 71 70 70 69 
Leu:Lys 204 182 167 156 
Met:Lys 35 32 30 30 
Met & Cys:Lys 73 66 61 60 
Thr:Lys 65 65 64 65 
Trp:Lys 18 18 19 19 
Val:Lys 89 84 81 79 
ME, kcal/kg 3,494 3,494 3,492 3,492 
Total Lys, % 0.59 0.74 0.88 1.02 
CP, % 11.4 13.4 15.5 17.5 
Ca, % 0.45 0.46 0.48 0.49 
P, % 0.39 0.40 0.42 0.43 
Available P, %
6
 0.23 0.23 0.23 0.23 
1
A total of 930 gilts (PIC 337 × 1050) were used in this 28-d trial with 5 replications per PCV2 
vaccination and diet combination. 
2
A total of 825 barrows (PIC 337 × 1050) were used in this 21-d trial with 5 replications per 
PCV2 vaccination and diet combination. 
3
Standardized ileal digestible. 
4
Vitamin and trace mineral premix provided per kg of diet: 3,608 IU of vitamin A, 561.2 IU of 
vitamin D3, 19.24 IU of vitamin E, 1.12 mg of vitamin K, 2.41 mg of Riboflavin, 12.03 mg of 
vitamin B12, 14.43 mg of Niacin, 9.62 mg of pantothenic acid, 32.07 mg of Mn from Mn oxide, 
80.17 mg Zn from Zn sulfate, 72.15 mg Fe from Fe sulfate, 8.02 mg Cu from Cu sulfate, 0.24 mg 
of Se from Na selenite, and 0.40 mg of I from EDDI.  
5
OptiPhos 2000 (Enzyvia; Sheridan, IN) provided (per kg of complete diet) 500 FTU of phytase. 
6
Phytase provided 0.10% available P to the diet. 
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Table 2-5. Chemical composition of diets (Exp. 3)
1
 
 
SID
2
 lysine:ME, g/Mcal 
 
1.49 1.86 2.23 2.61 
 
SID lysine, % 
 Item, % 0.52 0.65 0.78 0.91 
CP 9.8 (11.4)
3
 10.8 (13.4) 13.7 (15.5) 15.2 (17.5) 
Essential amino acids 
    Arg 0.61 0.69 0.89 1.02 
His 0.28 0.31 0.38 0.44 
Ile 0.43 (0.42) 0.48 (0.52) 0.61 (0.62) 0.70 (0.71) 
Leu 1.05 (1.16) 1.08 (1.30) 1.29 (1.44) 1.47 (1.57) 
Lys 0.57 (0.59) 0.68 (0.74) 0.87 (0.88) 0.96 (1.02) 
Met 0.17 (0.20) 0.21 (0.23) 0.25 (0.26) 0.28 (0.30) 
Met + Cys 0.35 (0.43) 0.40 (0.48) 0.48 (0.54) 0.53 (0.61) 
Phe 0.58 0.61 0.76 0.84 
Thr 0.39 (0.41) 0.45 (0.50) 0.57 (0.59) 0.64 (0.68) 
Trp 0.10 (0.11) 0.12 (0.14) 0.16 (0.17) 0.18 (0.20) 
Val 0.49 (0.53) 0.52 (0.62) 0.66 (0.72) 0.74 (0.82) 
Nonessential amino acids 
    Ala 0.65 0.67 0.78 0.87 
Asp 0.93 1.07 1.41 1.62 
Cys 0.18 0.19 0.23 0.25 
Glu 1.81 1.97 2.49 2.83 
Gly 0.41 0.46 0.58 0.65 
Pro 0.75 0.29 1.11 1.27 
Ser 0.50 0.56 0.70 0.79 
Tyr 0.33 0.34 0.42 0.47 
1
A total of 930 gilts (PIC 337 × 1050) were used in this 28-d trial with 5 replications per PCV2 
vaccination and diet combination. 
2
Standardized ileal digestible.  
3
Values in parentheses indicate formulated values. 
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Table 2-6. Chemical composition of diets (Exp. 4)
1
 
 
SID
2
 lysine:ME, g/Mcal 
 
1.49 1.86 2.23 2.61 
 
SID lysine, % 
 Item, % 0.52 0.65 0.78 0.91 
CP 9.7 (11.4)
3
 10.9 (13.4) 13.6 (15.5) 15.1 (17.5) 
Essential amino acids 
    Arg 0.60 0.71 0.92 0.98 
His 0.28 0.32 0.38 0.41 
Ile 0.43 (0.42) 0.49 (0.52) 0.62 (0.62) 0.66 (0.71) 
Leu 1.05 (1.16) 1.11 (1.30) 1.31 (1.44) 1.40 (1.57) 
Lys 0.56 (0.59) 0.68 (0.74) 0.87 (0.88) 0.93 (1.02) 
Met 0.20 (0.20) 0.19 (0.23) 0.25 (0.26) 0.26 (0.30) 
Met + Cys 0.38 (0.43) 0.38 (0.48) 0.48 (0.54) 0.51 (0.61) 
Phe 0.58 0.64 0.76 0.83 
Thr 0.42 (0.41) 0.45 (0.50) 0.58 (0.59) 0.64 (0.68) 
Trp 0.10 (0.11) 0.12 (0.14) 0.16 (0.17) 0.17 (0.20) 
Val 0.48 (0.53) 0.53 (0.62) 0.67 (0.72) 0.72 (0.82) 
Nonessential amino acids 
    Ala 0.64 0.67 0.78 0.84 
Asp 0.93 1.10 1.44 1.56 
Cys 0.18 0.19 0.23 0.25 
Glu 1.81 2.03 2.54 2.73 
Gly 0.41 0.47 0.58 0.63 
Pro 0.59 0.67 0.71 1.18 
Ser 0.50 0.57 0.71 0.77 
Tyr 0.32 0.36 0.43 0.45 
1
A total of 825 barrows (PIC 337 × 1050) were used in this 21-d trial with 5 replications per 
PCV2 vaccination and diet combination. 
2
Standardized ileal digestible.  
3
Values in parentheses indicate formulated values. 
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Table 2-7. Effects of porcine circovirus type 2 (PCV2) vaccination and gender on growth 
performance during the pre-trial period
1
 
 
      
Probability, P < 
 
Barrow 
 
Gilt 
 
Gender × 
vaccine   PCV2 vaccination: No Yes 
 
No Yes SEM Vaccine Gender 
Initial wt, kg 5.7 5.7 
 
5.7 5.7 0.17 0.99 0.99 0.99 
d 0 to 15
2
 
         
ADG, g 266 264 
 
270 270 15.2 0.95 0.93 0.75 
ADFI, g 394 372 
 
396 392 18.4 0.62 0.46 0.55 
G:F 0.67 0.71 
 
0.68 0.69 0.017 0.30 0.15 0.48 
d 15 to 29
3
 
         
ADG, g 420 403 
 
445 417 9.2 0.56 0.02 0.04 
ADFI, g 651 614 
 
682 651 15.9 0.88 0.04 0.04 
G:F 0.65 0.66 
 
0.65 0.64 0.006 0.07 0.87 0.45 
d 29 to 50
4
 
         
ADG, g 408 437 
 
382 418 18.3 0.85 0.08 0.22 
ADFI, g 731 725 
 
706 726 29.6 0.66 0.81 0.69 
G:F 0.56 0.60 
 
0.54 0.58 0.007 0.54 0.001 0.005 
d 0 to 50 
         
ADG, g 369 375 
 
366 373 13.8 0.99 0.62 0.86 
ADFI, g 607 588 
 
606 604 21.4 0.69 0.63 0.71 
G:F 0.61 0.64 
 
0.60 0.62 0.006 0.09 0.001 0.03 
Final wt, kg 24.4 24.5 
 
24.2 24.5 0.80 0.94 0.82 0.88 
1
A total of
 
2,571 barrows and gilts (PIC 337 × 1050) were double stocked into a wean-to-finish 
barn and observed for 50 d to determine the effects of PCV2 vaccine on growth performance.  
2
The first PCV2 vaccine was given on d 1 of this study to the selected pens of pigs.  
3
The second PCV2 vaccine was given on d 22 of the study to the selected pens of pigs.  
4
All pigs were injected with live PRRS virus on d 30.  
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Table 2-8. Effects of porcine circovirus type 2 (PCV2) vaccination and gender on pigs 
remaining on test
1
 
       
Probability, P < 
 
Barrow 
 
Gilt 
 
Gender × 
vaccine 
    
PCV2 vaccination: No Yes   No Yes SEM Vaccine Gender 
d 0 pen count, no. 55.8 55.8 
 
56.0 56.0 
    
Pigs remaining, % 
d 15
2
 99.7 99.5 
 
99.3 99.6 0.31 0.39 0.41 0.76 
d 29
3
 98.8 99.3 
 
99.3 99.1 0.39 0.38 0.74 0.66 
d 50
4
 95.1 98.7 
 
96.2 97.5 1.01 0.25 0.38 0.39 
1
A total of
 
2,571 barrows and gilts were double stocked into a wean-to-finish barn and observed 
for 50 d to determine the effects of PCV2 vaccine on nursery growth performance.  
2
Time period after the first PCV2 vaccine (d 1).  
3
Time period after the second PCV2 vaccine (d 22).  
4
Time period after all pigs were injected with live PRRS virus (d 30).  
5
Day 71 corresponds to the beginning of Exp. 1 and 2. 
6
Day 99 corresponds to the conclusion of Exp. 1 and 2.   
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Table 2-9. Effects of SID lysine:ME ratio and PCV2 vaccination on 40- to 60- kg gilts (Exp. 1)
1
 
 
PCV2 vaccine
2
 
 
Probability, P < 
 
No 
 
Yes 
 
Vaccine × 
Lysine   
Lysine 
SID lysine:ME, g/Mcal: 2.24 2.61 2.99 3.36   2.24 2.61 2.99 3.36 SEM Vaccine Lysine Linear Quadratic 
Initial wt, kg 37.5 37.5 37.5 37.5 
 
39.1 39.1 39.2 39.1 1.25 1.00 0.08 1.00 0.99 0.99 
Initial pen head count 23.0 23.8 23.0 23.8 
 
26.8 27.2 27.0 27.0 0.77 0.96 0.001 0.84 0.69 0.86 
ADG, kg 0.69 0.73 0.78 0.74 
 
0.81 0.87 0.86 0.84 0.017 0.33 0.001 0.002 0.02 0.002 
ADFI, kg 1.63 1.64 1.61 1.59 
 
1.84 1.84 1.79 1.75 0.038 0.88 0.001 0.22 0.06 0.45 
G:F 0.42 0.44 0.48 0.47 
 
0.44 0.47 0.49 0.48 0.012 0.67 0.10 0.001 0.001 0.04 
Final wt, kg 58.0 59.4 60.4 59.1 
 
61.7 63.5 63.4 62.5 1.35 0.99 0.001 0.48 0.46 0.18 
Final pen head count 21.2 22.0 21.6 22.8 
 
26.8 27.2 26.8 27.0 0.71 0.80 0.001 0.60 0.31 0.93 
Daily SID lysine intake, g 12.68 14.92 16.78 18.58 
 
14.33 16.77 18.56 20.43 0.390 0.99 0.001 0.001 0.001 0.37 
SID lysine intake/kg gain, g 18.43 20.55 21.56 25.11 
 
17.79 19.30 21.48 24.50 0.578 0.80 0.13 0.001 0.001 0.09 
1
A total of 1,008 gilts (PIC 337 × 1050) were used in this 28-d trial with 5 replications per PCV2 vaccination and diet combination. 
2
Vaccination for PCV2 was administered at placement into the wean-to-finish facility and again 3 wk later.  
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Table 2-10. Effects of SID lysine:ME ratio and PCV2 vaccination on 40 to 65 kg barrows (Exp. 2)
1
 
 
PCV2 vaccine
2
 
 
Probability, P < 
 
No 
 
Yes 
 Vaccine 
× Lysine 
  
Lysine 
SID lysine:ME, g/Mcal: 2.24 2.61 2.99 3.36  
2.24 2.61 2.99 3.36 SEM Vaccine Lysine Linear Quadratic 
Initial wt, kg 37.8 37.8 37.8 37.9 
 
39.9 39.9 39.8 39.9 1.47 1.00 0.06 1.00 0.97 0.99 
Initial pen head count 23.0 22.4 22.6 23.4 
 
27.4 27.0 27.4 27.2 0.72 0.91 0.001 0.85 0.80 0.44 
ADG, kg 0.80 0.78 0.87 0.87 
 
0.93 0.94 0.93 0.96 0.032 0.44 0.001 0.39 0.13 0.66 
ADFI, kg 1.98 1.87 1.90 1.84 
 
2.15 2.15 2.05 2.05 0.067 0.77 0.001 0.31 0.07 0.86 
G:F 0.40 0.42 0.46 0.47 
 
0.43 0.44 0.45 0.47 0.009 0.18 0.10 0.001 0.001 0.63 
Final wt, kg 61.8 63.1 64.3 64.9 
 
66.1 66.5 65.8 66.9 1.79 0.87 0.04 0.77 0.30 0.99 
Final pen head count 21.4 18.8 19.8 20.4 
 
27.2 26.6 27.4 27.0 0.90 0.67 0.001 0.38 0.76 0.19 
Daily SID lysine intake, g 15.45 17.03 19.80 21.47 
 
16.77 19.58 21.32 23.95 0.653 0.71 0.001 0.001 0.001 0.96 
SID lysine intake/kg gain, g 19.40 21.94 22.86 24.84 
 
17.99 20.79 22.97 25.13 0.480 0.22 0.13 0.001 0.001 0.37 
1
A total of 1,002 barrows (PIC 337 × 1050) were used in this 28-d trial with 5 replications per PCV2 vaccination and diet combination. 
2
Vaccination for PCV2 was administered at placement into the wean-to-finish facility and again 3 wk later.   
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Table 2-11. Effects of SID lysine:ME ratio and PCV2 vaccination on 100 to 125 kg gilts (Exp. 3)
1
 
 
PCV2 vaccine
2
 
 
Probability, P < 
 
No 
 
Yes 
 Vaccine 
× Lysine 
  
Lysine 
SID lysine:ME, g/Mcal: 1.49 1.86 2.23 2.61   1.49 1.86 2.23 2.61 SEM Vaccine Lysine Linear Quadratic 
Initial wt, kg 100.1 100.0 100.1 100.1 
 
103.3 103.4 103.3 103.4 1.37 0.99 0.002 0.99 0.98 0.98 
Initial pen head count 20.4 20.2 20.4 20.6 
 
22.6 22.2 22.4 22.4 0.69 0.99 0.001 0.97 0.93 0.69 
ADG, kg 0.74 0.83 0.84 0.82 
 
0.76 0.84 0.84 0.87 0.027 0.79 0.24 0.005 0.003 0.05 
ADFI, kg 2.72 2.71 2.62 2.59 
 
2.68 2.68 2.56 2.64 0.061 0.79 0.60 0.21 0.09 0.75 
G:F 0.27 0.31 0.32 0.32 
 
0.29 0.31 0.33 0.33 0.006 0.91 0.02 0.001 0.001 0.001 
Final wt, kg 120.7 123.2 123.5 123.1 
 
125.0 126.8 126.9 127.8 1.46 0.97 0.001 0.27 0.10 0.36 
Final pen head count 20.4 20.2 20.4 20.4 
 
22.2 22.2 22.4 22.4 0.70 0.99 0.001 0.99 0.83 0.92 
Daily SID lysine intake, g 14.14 17.64 20.44 23.56 
 
13.91 17.39 19.94 24.0 0.44 0.72 0.70 0.001 0.001 0.86 
SID lysine intake/kg gain, g 19.37 21.31 24.47 28.92 
 
18.28 20.82 23.76 27.67 0.470 0.85 0.02 0.001 0.001 0.007 
Carcass measurements 
               
Backfat, mm 16.0 15.4 14.9 15.8 
 
16.5 16.5 16.3 16.4 0.66 0.84 0.03 0.67 0.62 0.32 
Lean, % 56.4 55.9 56.5 56.0 
 
56.3 56.5 56.4 56.4 0.70 0.91 0.71 0.97 0.89 0.91 
Loin depth, cm 6.13 6.22 6.27 6.19 
 
6.27 6.43 6.23 6.28 0.177 0.86 0.35 0.87 0.95 0.51 
Yield, % 75.6 75.7 75.9 75.5 
 
76.4 75.6 75.5 75.4 0.50 0.54 0.87 0.67 0.25 0.94 
FFLI, %
3
 50.9 51.1 51.4 51.0 
 
50.8 50.9 50.9 50.9 0.28 0.86 0.18 0.67 0.54 0.35 
1
A total of 930 gilts (PIC 337 × 1050) were used in this 28-d trial with 5 replications per PCV2 vaccination and diet combination. 
2
Vaccination for PCV2 was administered at placement into the wean-to-finish facility and again 3 wk later. 
3
Fat-free lean index. 
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Table 2-12. Effects of SID lysine:ME ratio and PCV2 vaccination on 97 to 118 kg barrows (Exp. 4)
1 
 
PCV2 vaccine
2
  
 
Probability, P < 
 
No 
 
Yes 
 
Vaccine 
× lysine 
  
Lysine 
SID lysine:ME, g/Mcal: 1.49 1.86 2.23 2.61 
 
1.49 1.86 2.23 2.61 SEM Vaccine Lysine Linear Quadratic 
Initial wt, kg 97.6 97.6 97.4 97.6 
 
97.8 97.8 97.8 97.8 1.97 1.00 0.86 1.00 0.99 0.99 
Initial day pen head count 18.2 19.0 19.2 18.2 
 
22.8 22.6 22.6 22.4 0.89 0.91 0.001 0.91 0.86 0.48 
ADG, kg 0.92 0.97 0.97 1.02 
 
0.86 0.91 0.95 1.02 0.019 0.36 0.02 0.001 0.001 0.81 
ADFI, kg 3.04 3.24 3.23 3.08 
 
2.94 2.98 3.11 3.04 0.083 0.62 0.04 0.19 0.31 0.06 
G:F 0.30 0.30 0.30 0.33 
 
0.30 0.31 0.31 0.34 0.008 0.81 0.70 0.001 0.001 0.03 
Final wt, kg 117.5 118.0 117.9 119.0 
 
116.1 117.0 117.8 119.3 1.81 0.96 0.68 0.63 0.21 0.84 
Final pen head count 18.0 19.0 19.0 18.2 
 
22.4 22.6 22.4 22.4 0.90 0.94 0.001 0.89 0.95 0.44 
Daily SID lysine intake, g 15.80 21.07 25.20 28.07 
 
15.29 19.38 24.25 27.65 0.583 0.69 0.04 0.001 0.001 0.07 
SID lysine intake/kg gain, g 17.28 21.72 25.89 27.58 
 
17.78 21.25 25.66 27.04 0.561 0.79 0.65 0.001 0.001 0.005 
Carcass measurements 
               
Backfat, mm 19.5 19.1 19.3 19.5 
 
20.5 20.1 19.5 19.3 0.61 0.74 0.24 0.70 0.29 0.63 
Lean, % 54.0 54.1 54.0 53.8 
 
53.0 53.4 53.9 54.0 0.48 0.59 0.29 0.79 0.37 0.66 
Loin depth, cm 5.84 5.73 5.72 5.63 
 
5.44 5.62 5.79 5.77 0.164 0.38 0.52 0.92 0.63 0.72 
Yield, % 74.3 74.6 74.6 74.1 
 
74.8 74.8 74.8 74.8 0.51 0.95 0.25 0.96 0.93 0.60 
FFLI, %
3
 48.8 49.1 49.0 48.9 
 
48.2 48.5 48.8 49.0 0.28 0.55 0.11 0.47 0.16 0.48 
1
A total of 825 barrows (PIC 337 × 1050) were used in this 21-d trial with 5 replications per PCV2 vaccination and diet combination. 
2
Vaccination for PCV2 was administered at placement into the wean-to-finish facility and again 3 wk later. 
3
Fat-free lean index. 
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CHAPTER 3 - Effects of copper sulfate, tri-basic copper chloride, 
and zinc oxide on weanling pig performance 
Abstract 
Three experiments were conducted to evaluate the effects of increasing dietary Cu and Zn 
concentrations on weanling pig performance. Diets were fed in 2 phases: phase 1 from d 0 to 14 
post-weaning and phase 2 from d 14 to 28 in Exp. 1 and 2 and d 14 to 42 in Exp. 3. The trace 
mineral premix, included in all diets, provided 165 ppm Zn and 16.5 ppm Cu. In Exp. 1, 
treatments were arranged in a 2 × 3 factorial with main effects of added Cu from tri-basic copper 
chloride (TBCC; 0 or 150 ppm) and added Zn from zinc oxide (ZnO; 0, 1,500, or 3,000 ppm 
from d 0 to 14 and 0, 1,000, or 2,000 ppm from d 14 to 28). No Cu × Zn interactions were 
observed (P > 0.10) for any of the growth data. Adding TBCC increased (P < 0.03) ADG and 
ADFI during each phase. Increasing dietary Zn also increased (linear, P < 0.04) ADG and ADFI 
during each phase. In Exp. 2, treatments were arranged in a 2 × 3 factorial with main effects of 
added Zn from ZnO (0 or 3,000 ppm from d 0 to 14 and 0 or 2,000 ppm from d 14 to 28) and Cu 
(control, 125 ppm Cu from TBCC, or 125 ppm Cu from copper sulfate; CuSO4). No Cu × Zn 
interactions (P > 0.10) were observed for any performance data. Adding ZnO improved (P < 
0.02) ADG and ADFI from d 0 to 14 and overall. From d 0 to 28, supplementing CuSO4 
increased (P < 0.02) ADG, ADFI, and G:F, and TBCC improved (P = 0.006) ADG. In Exp. 3, 
the 6 dietary treatments were arranged in a 2 × 2 factorial with main effects of added Cu from 
CuSO4 (0 or 125 ppm) and added Zn from ZnO (0 or 3,000 ppm from d 0 to 14 and 0 or 2,000 
ppm from d 14 to 42). The final 2 treatments were feeding added ZnO alone or in combination 
with CuSO4 from d 0 to 14 and adding CuSO4 from d 14 to 42. Adding ZnO increased (P < 
0.04) ADG, ADFI, and G:F from d 0 to 14 and ADG from d 0 to 42. Dietary CuSO4 increased (P 
< 0.004) ADG and ADFI from d 14 to 42 and d 0 to 42. From d 28 to 42, a trend for a Cu × Zn 
interaction was observed (P = 0.06) for ADG. This interaction was reflective of the numeric 
decrease in ADG for pigs when Cu and Zn were used in combination compared with each used 
alone. Also, numerical advantages were observed when supplementing Zn from d 0 to 14 and Cu 
from d 14 to 42 compared with all other Cu and Zn regimens. These 3 experiments show 
advantages to including both Cu and Zn in the diet for 28 d post-weaning; however, as evident in 
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Exp. 3, when Zn was added early and Cu was added late, performance was similar or 
numerically greater than when both were used for 42 d.  
Key Words: copper, growth, weanling pig, zinc 
Introduction 
Zinc and Cu are two minerals commonly added at pharmacological concentrations to 
weanling pig diets to serve as growth promoters. Nursery studies have demonstrated that 
increased dietary concentrations of Zn can promote growth rates (Hahn and Baker, 1993; Smith 
et al., 1997; Carlson et al., 1999; Hill et al., 2001; Williams et al., 2005;) and increase stool 
firmness (Hill et al., 2000). The greatest response to pharmacological concentrations of Zn is 
observed when 3,000 ppm is provided for the first 2 to 4 wk postweaning (Carlson et al., 1999; 
Woodworth et al., 2005). Zinc oxide (ZnO) is the most common form used to increase growth 
(Hahn and Baker, 1993; Schell and Kornegay, 1996; Hollis et al., 2005).   
Dietary Cu also has been shown to enhance growth rates in weanling pigs (Stahly et al., 
1980; Cromwell et al., 1989; 1998; Hill et al., 2000). Supplemental Cu is most efficacious for 
weanling pigs at 200 to 250 ppm (Cromwell, 2001), and 125 ppm offers 75% of the growth 
response achieved with 250 ppm (Cromwell et al., 1989). The sulfate form of Cu historically has 
been used because of its improved performance compared with the oxide form (Cromwell et al., 
1989). However, Cromwell et al. (1998) observed similar growth-promoting effects when adding 
Cu from either tri-basic copper chloride (TBCC) or copper sulfate (CuSO4) and showed that 
TBCC may be more efficacious at lower levels than CuSO4.  
Historically, use of high concentrations of both Zn (3,000 ppm) and Cu (250 ppm) has 
not shown additive effects (Smith et al., 1997; Hill et al., 2000).  However, Perez-Mendoza et al. 
(2008) observed improved growth when nursery pigs were fed supplemental CuSO4 along with 
pharmacological Zn at 3,000 ppm. Also, the effect of moderate concentrations of Cu (100 to 150 
ppm) combined with high pharmacological Zn has not been evaluated. Therefore, the objective 
of these experiments was to characterize the effect of combining ZnO with moderate 
concentrations  of TBCC or CuSO4 on nursery pig growth performance and blood plasma 
minerals. 
Materials and Methods 
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General 
Protocols used in these experiments were approved by the Kansas State University 
Institutional Animal Care and Use Committee. Experiments 1 and 3 were conducted at the 
Kansas State University Swine Teaching and Research Center, and Exp. 2 was conducted at the 
Kansas State University Segregated Early Weaning Facility.  
Each pen contained a 4-hole, dry self-feeder and either a cup or nipple waterer, 
depending on facility, to provide ad libitum access to feed and water. Pens had metal woven-wire 
flooring in Exp. 1 and 3 and metal tri-bar flooring in Exp. 2 while allowing 0.30 m
2
 per pig. 
Weights and feed disappearance were measured weekly to determine ADG, ADFI, and G:F.  
Similar diets were used in each of the 3 experiments (Table 1). The phase 1 diet was fed 
for the first 14 d postweaning, and the phase 2 diet was fed for the remainder of the trial (14 d in 
Exp. 1 and 2 and 28 d in Exp. 3). Diets were fed in meal form and were formulated to contain 
1.41 and 1.31% standardized ileal digestible lysine, respectively. Phase 1 diets contained 15% 
spray-dried whey and 3.75% fish meal. Phase 2 diets were corn-soybean meal based without 
specialty protein sources. All diets contained a trace mineral premix that supplied 165 ppm Zn 
from zinc sulfate (ZnSO4) and 16.5 ppm Cu from CuSO4. All other nutrients were formulated to 
meet or exceed NRC (1998) requirements. To generate treatment diets, ZnO, TBCC, and CuSO4 
were added in place of corn starch to achieve the desired Zn and Cu concentrations. Treatment 
diets were sampled in each experiment and analyzed for Cu and Zn concentrations. Samples 
were digested with HNO3 and H2O2 and then analyzed for Cu and Zn by the atomic absorption 
spectrophotometric method. Calculated values were determined using the amount added from the 
trace mineral premix, any added Cu or Zn supplementation based on treatment, and the amount 
provided by other dietary ingredients using values from NRC (1998). 
Blood samples were collected from 2 pigs per pen (d 14 in Exp. 1, d 14 and 28 in Exp. 2, 
and d 14 and 42 in Exp. 3) by jugular venapuncture. On d 14, pigs were weighed and diets were 
changed at approximately 0800 h, and blood was collected at 1300 h. On d 28 in Exp. 2 and d 42 
in Exp. 3, pigs were again weighed at 0800 h, and blood was collected at 1300 h. However, on 
the final day of the trial, pigs were provided the same diet that was offered prior to weighing. 
Blood samples were stored on ice for approximately 1 h until they were centrifuged at 1,600 × g 
for 20 min at 4°C. Plasma was then collected from each blood sample, frozen, and sent to 
Michigan State University (East Lansing, MI) for mineral analysis. Copper and Zn 
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concentrations were determined by flame atomic absorption spectrophotometry (Smith-Hieftje 
4000, Thermo Jarrell Ash Corp., Franklin, MA), and P was measured by color 
spectrophotometry. 
Experiment 1 
Weanling pigs (n=180; TR4 ×1050; PIC, Hendersonville, TN; initially 5.7 kg and 21 d of 
age) were allotted by initial BW in a RCBD. There were 5 pens per treatment with 6 pigs per 
pen. Treatments were arranged in a 2 × 3 factorial with main effects of added Cu from TBCC (0 
or 150 ppm) and added Zn from ZnO ( 0, 1,500, or 3,000 ppm from d 0 to 14 and 0, 1,000, or 
2,000 ppm from d 14 to 28).  
Experiment 2  
Weanling pigs (n=180; PIC 1050; initially 6.0 kg and 21 d of age) were allotted by initial 
BW in a RCBD for this 28-d trial. There were 6 pens per treatment with 5 pigs per pen. 
Treatments were arranged in a 2 × 3 factorial with main effects of added Zn from ZnO (0 or 
3,000 ppm from d 0 to 14 and 0 or 2,000 ppm from d 14 to 28) and added Cu sources (0, 125 
ppm Cu from TBCC, or 125 ppm Cu from CuSO4).  
Experiment 3 
Weanling pigs (n=216; PIC TR4 ×1050, initially 6.2 kg and 21 d of age) were fed in a 
42-d growth trial to compare the effects of supplemental Zn and Cu and observe the effects of 
changing mineral regimens. Pigs were allotted by initial BW in a RCBD. There were 6 pens per 
treatment with 6 pigs per pen. Treatments were arranged in a 2 × 2 factorial with main effects of 
added Cu from CuSO4 (0 or 125 ppm) and added Zn from ZnO (0 or 3,000 ppm from d 0 to 14 
and 0 or 2,000 ppm from d 14 to 42). Two additional treatments were included in which the 
added ZnO or ZnO and CuSO4 diet was fed from d 0 to 14 with added CuSO4 fed from d 14 to 
42.  
Statistical Analysis 
Pen was the experimental unit for all analysis, and data from each experiment were 
analyzed using the MIXED procedure in SAS (SAS Institute Inc., Cary, NC). Each study was 
analyzed as a RCBD, and initial BW was used to establish blocks. Blocks were treated as 
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random effects in the model. Also in each model, Cu and Zn effects were treated as fixed effects. 
Experiment 1 was analyzed in a 2 × 3 factorial arrangement with 2 Cu and 3 Zn concentrations. 
Contrast statements were used to evaluate linear and quadratic polynomial effects associated 
with increasing dietary Zn. Experiment 2 also was analyzed in a 2 × 3 factorial arrangement with 
main effects of 2 Zn concentrations and 3 sources of added Cu. Contrast statements were used to 
separate differences between Cu sources. In Exp. 3, main effects and potential interactions for 
added Cu and Zn were tested using contrast statements. For Phase 1, growth performance was 
similar between both dietary treatments that were fed either the high Zn or high Cu and Zn diet; 
therefore, results were pooled to determine the main effects of Cu and Zn. For plasma mineral 
results, concentrations  were not similar between the 2 treatments receiving the same mineral 
regimen in both phases; therefore, only pigs remaining on the same regimen for both phases were 
used to test for main effects of Cu and Zn. In Phase 2 as well as for the overall trial, only 
treatments that remained on the same mineral regimen for the entire trial were used to determine 
the main effects of Cu and Zn. Effects were considered significant if their P-values were < 0.05 
and trends if their P-values were < 0.10.  
Results 
Laboratory analysis of the diets indicated that Cu and Zn concentrations  were similar to 
calculated values in Exp. 1, 2, and 3 (Tables 2, 3, and 4, respectively).  
Experiment 1  
No Cu × Zn interactions were observed (P > 0.10) for any of the performance criteria in 
Exp. 1 (Table 5). Increasing dietary Zn increased (linear, P < 0.003) both ADG and ADFI from d 
0 to 14. Dietary Cu from TBCC also increased (P < 0.02) ADG and ADFI compared with non-
Cu-supplemented treatments. However, dietary Cu and Zn additions did not influence G:F (P > 
0.10). 
From d 14 to 28, the addition of Cu from TBCC increased (P < 0.03) both ADG and 
ADFI. Also, increasing dietary Zn increased (linear, P < 0.04) both ADG and ADFI from d 14 to 
28. Feed efficiency was not influenced (P > 0.10) by adding Cu or Zn.  
Overall (d 0 to 28), adding Cu from TBCC improved (P < 0.007) both ADG and ADFI. 
The additions of dietary Zn from ZnO resulted in  (linear, P < 0.003) improvements in ADG and 
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ADFI. Pigs that were fed both added Cu and pharmacological Zn had the greatest numerical 
ADG and ADFI, and no interactions were observed.   
Inclusion of ZnO or TBCC had no effect (P > 0.10) on plasma Cu concentrations (Table 
6). However, Cu × Zn interactions were detected (P < 0.03) for both plasma Zn and P 
concentrations. The interaction for plasma Zn occurred because a greater increase in plasma Zn 
was observed as dietary Zn increased for pigs fed diets containing no added Cu compared to the 
response when TBCC was incorporated into the diet with increasing dietary Zn. The P 
interaction was due to plasma P increasing in pigs fed increasing dietary Zn  without added Cu, 
but decreased as Zn concentration increased in diets with supplemental Cu.      
Experiment 2 
No Cu × Zn interactions were observed (P > 0.10) for any of the growth criteria in Exp. 2 
(Table 7). From d 0 to 14, adding dietary Zn increased (P < 0.02) ADG, ADFI, and G:F. A main 
effect of Cu also was observed (P < 0.01) from d 0 to 14 for ADG, ADFI, and G:F. Pigs 
supplemented with Cu from CuSO4 had greater (P < 0.04) ADG, ADFI, and G:F than pigs 
supplemented with no Cu or with Cu from TBCC.   
From d 14 to 28, adding Cu from either CuSO4 or TBCC tended to increase (P < 0.08) 
ADG. Daily feed intake increased (P = 0.01) in pigs that were supplemented with Zn. Also, 
supplementing Cu from CuSO4 improved (P = 0.02) and from TBCC tended to improve (P = 
0.08) G:F compared with not adding supplemental Cu.  
Over the entire 28-d trial, pharmacological Zn increased (P < 0.01) ADG and ADFI. Pigs 
fed added CuSO4 had increased (P < 0.02) ADG, ADFI, and G:F compared with control pigs. 
Also, pig fed supplemental TBCC had greater (P = 0.006) ADG than control pigs. Pigs fed both 
pharmacological ZnO and CuSO4 had the greatest numeric ADG and ADFI.   
No Cu or Zn effects were observed for plasma Cu on d 14; however, plasma Zn 
concentrations  increased (P = 0.001) on d 14 and tended (P = 0.09) to be higher at d 28 for pigs 
supplemented with ZnO (Table 8).  A Cu × Zn interaction was detected (P = 0.02) on d 28. In 
diets containing no added Zn, plasma Cu numerically increased when TBCC was added to the 
diet but decreased when CuSO4 was added to the diet. The opposite was true in diets containing 
supplemental Zn, with plasma Cu numerically decreasing as TBCC was added to the diet and 
53 
 
increasing when CuSO4 was added to the diet.  Unlike Exp. 1, no dietary effects were observed 
(P > 0.10) for plasma P at either bleeding time. 
Experiment 3 
Pharmacological Zn improved (P < 0.04) ADG, ADFI, and G:F (Table 9), during phase 1 
(d 0 to 14). The addition of Cu did not improve (P > 0.10) ADG or G:F compared to pigs fed the 
control diet, but tended to increase (P = 0.07) ADFI. The numerically greatest ADG and ADFI 
responses were seen when pigs were fed both added Zn and Cu; however, these responses were 
only numerically greater (3%) than Zn used alone.  
From d 14 to 28, pharmacological Zn increased (P = 0.04) ADFI but had no effect on 
ADG (P = 0.10). Thus, G:F became worse (P = 0.02) when Zn was added to the diet. Added 
dietary Cu also increased (P < 0.003) ADG and ADFI and tended to improve (P = 0.06) G:F. As 
pigs were switched from supplemental Zn in phase 1 to added Cu, ADG improved (P < 0.05) 
compared with maintaining a high concentration of Zn. Conversely, when pigs were switched 
from high concentrations of added Cu and Zn to added Cu alone, performance was not improved 
(P > 0.05) compared with adding both minerals.  
From d 28 to 42, a trend for a Cu × Zn interaction was observed (P = 0.06) for ADG. 
This interaction was reflective of the numeric decrease in ADG for pigs fed pharmacological  Cu 
and Zn  in combination compared with each fed separately. Pigs fed pharmacological Cu had 
increased (P < 0.04) ADFI and lower G:F than pigs not supplemented with Cu for this 2 wk 
period.  
During dietary phase 2 (d 14 to 42), pigs fed pharmacological Cu had increased (P < 
0.003) ADG and ADFI. Pigs fed added Zn had lower (P = 0.04) G:F compared with those not 
supplemented with Zn. Pigs that were fed pharmacological concentrations of Zn from d 0 to 14 
and then fed pharmacological Cu for d 14 to 42 had increased (P < 0.05) ADG compared with 
pigs fed pharmacological Zn in both phases. 
For the entire study (d 0 to 42), pharmacological Zn and pharmacological Cu improved 
(P < 0.03)  ADG, with no interaction (P > 0.10). Feed intake was greater (P = 0.004) for pigs fed 
pharmacological Cu compared with those not receiving supplemental Cu. Final body weights 
were increased (P < 0.05) for each of the 5 regimens of pharmacological Cu and Zn compared 
with the control.   
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For blood plasma on d 14, no dietary effects were observed (P > 0.10) for plasma Cu 
concentration (Table 10). Plasma Zn concentrations increased (P = 0.001) when 
pharmacological  Zn was fed in phase 1 but not phase 2. Pigs whose mineral regimens were 
changed on d 14 from pharmacological Zn or Zn and Cu to only Cu had decreased (P < 0.05) 
plasma Zn compared with pigs remaining on the same regimen. The 5-h period in which pigs 
were allowed to eat the phase 2 diet may have generated the decrease in plasma Zn. No dietary 
main effects were observed (P > 0.10) for plasma P at either d 14 or 42. On d 42, trends for a Cu 
× Zn interaction were detected (P < 0.08) for both plasma Cu and Zn. The plasma Cu interaction 
was due to a numeric increase in plasma Cu compared with the control diet when Cu was added 
to the diet alone; no difference in plasma Cu was observed when Cu and Zn were added together. 
The plasma Zn interaction was due to a greater increase in plasma Zn when Zn was added alone 
in the diet compared with adding both Cu and Zn. 
Discussion 
Zinc supplementation in each of these 3 experiments increased feed intake, which 
resulted in increased overall ADG of 12.6, 10.8, and 7.0% for Exp. 1, 2, and 3, respectively 
compared to pigs not supplemented with Zn. Each of the experiments showed an advantage to 
supplementing 3,000 ppm Zn in the first 2 wk postweaning, similar to Carlson et al. (1999). 
Hahn and Baker (1993) observed 14.5 and 12.4% improvements in daily gain with 3,000 ppm Zn 
supplementation that were related to 13.5 and 12.8% increases in feed intake, in 35-d and 28-d 
old pigs after they had been placed on common diets for 7-d post-weaning . Hollis et al. (2005) 
observed an 11.9% improvement in ADG when adding 2,500 ppm Zn from ZnO for 28 d post-
weaning compared with no supplemental Zn. Hill et al. (2001) reported that improvements in 
growth from adding high concentrations of Zn were additive to effects of antimicrobial agents 
(carbadox).  
The source of added Zn seems to be an important factor in observing positive responses 
in pig performance. Hahn and Baker (1993) showed that ZnSO4 and a Zn-Met complex increased 
plasma Zn concentrations much greater than ZnO, which suggests an increase in the uptake of Zn 
from the small intestine. The sulfate and amino acid forms of Zn are absorbed at a greater rate 
than ZnO (Wedekind et al., 1994; Schell and Kornegay, 1996), and other researchers have 
hypothesized that lower concentrations of ZnSO4 or Zn amino acid complexes (ZnAA) could be 
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included in the diet to elicit a growth response while reducing Zn excretion. Hollis et al. (2005) 
showed that an additional 500 ppm Zn from either ZnO or organic sources of Zn did not improve 
ADG compared with normal values; however 3,000 ppm Zn from ZnO increased performance. 
Woodworth (1999) also showed that pigs fed 100 to 500 ppm of either ZnSO4 or a ZnAA 
complex had intermediate growth rates to the pigs fed 165 or 3,165 ppm Zn from ZnO. 
Therefore, ZnO is the only form used to achieve pharmacological levels of Zn in the diet to 
improve growth in nursery pigs.  
Copper supplementation also improved ADG in these experiments; TBCC improved 
daily gain by 9.0 and 9.7% in Exp. 1 and 2, respectively, and CuSO4 improved ADG by 17.9 and 
7.1% in Exp. 2 and 3, respectively. These increases were primarily due to increases in feed 
intake. Hence, Cu supplementation also improved G:F (Exp. 2). Cromwell (2001) summarized 
23 studies on the influence of adding 200 to 250 ppm Cu from CuSO4 on pig performance from 8 
to 20 kg. In this text, he calculated an 11.9% improvement in growth and a 4.5% improvement in 
feed efficiency due to CuSO4 addition. Perez-Mendoza et al. (2008) also observed increases in 
growth through 6 wk post-weaning with 315 ppm supplemental Cu from CuSO4. In addition, 
Stahly et al. (1980) pooled the results of 4 trials comparing the use of CuSO4 and antibiotic 
supplementation and determined that the effect of Cu supplementation was independent of the 
response of growth-promoting levels of antibiotics.  
The concentration and source of added Cu also affect the response. Cromwell et al. 
(1989) observed a curvilinear response in gain to increasing concentrations of dietary Cu from 
CuSO4 and, on the basis of the inflection point, calculated the greatest response at 242 ppm. 
Additional studies have shown the ideal amount of added Cu from CuSO4 to promote growth is 
between 125 and 250 ppm (Stahly et al., 1980; Roof and Mahan, 1982; Coffey et al., 1994). 
Cuprous oxide added at either 125 or 250 ppm does not elicit a growth response (Cromwell et 
al., 1989); however, a Cu-Lys complex has shown similar growth responses when compared with 
CuSO4 (Coffey et al. 1994; Apgar et al. 1995). Using liver concentrations as the response 
criteria, Apgar and Kornegay (1996) determined that absorption of Cu from a Cu-Lys was 
similar to that of Cu from CuSO4. Cromwell et al. (1998) also observed similar performance in 
weanling pigs that were supplemented with Cu from either TBCC or CuSO4. Therefore, it 
appears that under some conditions, pharmacological concentrations of Cu from CuSO4, a Cu-
lysine complex, or TBCC can be added to pig diets to promote growth.  
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Contrary to our results, inclusion of both Cu and Zn at pharmacological concentrations 
does not always show additive effects in weanling pigs (Smith et al., 1997; Hill et al. 2000). In 
previous experiments, Cu and Zn were added to diets that contained growth-promoting levels of 
antibiotics, whereas in our experiment, diets contained no additional antimicrobials. Responses 
of Zn or Cu have been shown to be additive to other antimicrobial agents (Stahly et al., 1980; 
Hill et al., 2001; Woodworth et al., 2005); however, the combination of all 3 may not be additive 
in nature. Perez-Mendoza et al. (2008) observed a 15.6% improvement in growth in the first 2 
wk postweaning when supplemental Cu was added to diets containing 3,000 ppm of added Zn, 
but the effect of Zn supplementation was not tested.  
Little research has been done to examine the effect of changing mineral regimens to 
validate the influence of switching from feeding Zn in the initial diets after weaning to feeding 
Cu in later diets. Numerical benefits to this approach were found in Exp. 3. Switching mineral 
regimens can reduce diet cost because Zn is removed from diets fed later in the nursery period. 
Another major benefit of this approach is decreased excretion of Zn in manure. Zinc 
accumulation in soil has been shown to hinder some crop production (Takkar and Mann, 1978; 
Chaney, 1993). Rincker et al. (2005) showed that Zn excretion increases after approximately 9 d 
of feeding pharmacological Zn as the body stores become maximized. Therefore, adding Zn in 
the initial post-weaning diets followed by supplementing Cu in later diets may be a way to obtain 
the desired growth-promoting effects while limiting costs and minimizing the concentration of 
Zn excreted in manure.  
The mode or modes of action for adding Cu to weanling pig diets are unknown. 
Pharmacological Cu has not been shown to improve intestinal morphology (Hedemann et al., 
2006). Copper supplementation also has shown been shown to promote growth independently of 
antibiotic additions (Stahly et al., 1980; Roof and Mahan, 1982), indicating it may have a 
different mode of action than antibiotics.  
Modes of action for Zn supplementation also are unknown; however, several hypotheses 
have been generated. Poulsen (1989) suggested that pharmacological Zn prevented Escherichia 
coli diarrhea in weanling pigs. Pharmacological Zn from ZnO does not alter the level of E. coli 
excreted in fecal material (Jensen-Waern et al., 1998; Pulz and Carlson, 2007). Woodworth 
(1999) suggested that added Zn prevents E. coli from creating a toxic environment in the 
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digestive system, possibly by preventing E. coli attachment and invasion of the enteric 
epithelium. Zinc does not appear to inhibit E. coli multiplication within the intestinal lumen.  
While Hahn and Baker (1993) suggested the mode of action for increased growth was 
related to plasma Zn concentrations. Pharmacological Zn increased plasma Zn on d 14 in our 3 
experiments, but our values did not approach the concentrations observed by Hahn and Baker 
(1993). Perhaps this may be due to the use of older pigs in that particular study compared with 
ours. Carlson et al. (1999) observed increased metallothionein concentration in the liver, kidney, 
and intestinal mucosa cells with pharmacological Zn supplementation. Metallothionein is a 
metal-binding protein associated with maintaining Zn homeostasis that is found throughout the 
body (Richards and Cousins, 1975) and is related to Zn absorption. Carlson et al. (1999) 
concluded that metallothionein synthesis in intestinal mucosal cells may facilitate Zn uptake into 
the body, resulting in improved growth performance.  
A third proposed mode of action for Zn supplementation is the potential for improved 
intestinal morphology (Carlson et al., 1999). Villus atrophy is a physiological event that occurs 
in newly weaned pigs (Hampson, 1986). Li et al. (2001) validated the previous report of Carlson 
et al. (1998) showing that pharmacological concentrations of Zn fed to weanling pig diets 
increased villus height and decreased crypt depth at 11 d post-weaning compared with not 
supplementing Zn. In contrast, Hedemann et al. (2006) observed no improvements in villus 
height of pigs weaned at 28-d of age with 2,500 ppm Zn supplementation for 14 d post-weaning. 
One factor that should be considered when interpreting those results is the timing of intestinal 
sample collection. Villus height has been shown to increase back to preweaning values as 
quickly as 9 d after weaning (Hedemann et al., 2003).  
In each of our 3 experiments, plasma Zn on d 14 increased linearly as Zn increased in the 
diet. Carlson et al. (1999) observed similar increases in plasma Zn when pigs of early and 
traditional weaning ages were fed 3,000 ppm Zn for 14 d post-weaning. Hahn and Baker (1993) 
also showed an increase in plasma Zn with supplementation of Zn from several sources. Hill et 
al. (2000) also observed increased plasma Zn concentrations with Zn supplementation; however, 
plasma Zn concentration was greater when dietary Cu and Zn were combined than when high 
concentrations of Zn were fed without Cu. This same numerical pattern was observed in Exp. 2, 
but the opposite was observed in Exp. 1 and 3. Also in Exp. 3, pigs switched from either high Zn 
or high Cu and Zn to high Cu on d 14 had decreased plasma Zn concentrations compared with 
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pigs that remained on the same mineral regimen in both phases. The 5-h period in which pigs 
were allowed to eat the phase 2 diet may have generated the decrease in plasma Zn. However, 
interaction of these 2 minerals in the liver and intestine could also alter this response.  
If pharmacological Zn is provided in weanling pig diets, metallothionein will increase in 
intestinal cells (Carlson et al., 1999). Then, Cu may be bound by metallothionein, limiting the 
amount of Zn that can be absorbed (Hill and Spears, 2001). This may be why plasma Zn 
increased to a greater degree in diets with no added Cu compared with diets containing added 
CuSO4. Hill et al. (2000) also observed an increase in plasma Cu concentration with Cu 
supplementation. Plasma Cu did not differ on d 14 in any of our experiments; however, 
interactions between Cu and Zn supplementation for plasma Cu at the end of Exp. 2 and 3 were 
observed. Interestingly, in Exp. 2, a numerical decrease in plasma Cu was observed for Cu from 
CuSO4 compared with other treatments. In Exp. 3, the Cu plasma concentration was increased 
with either Zn or Cu supplementation; however, when both minerals were combined, plasma Cu 
concentration was similar to that of the control. 
In conclusion, these experiments showed additive growth responses to supplementing Cu 
and Zn in the diet of weanling pigs for 28-d in these experiments. However, performance was 
numerically greater when mineral regimens were switched from feeding pharmacological Zn 
(3,000 ppm) for the first 14 d and moderate Cu (125 ppm) in later nursery phases than when both 
minerals were fed for the entire 42-d period. Also, removing Zn from later diets would decrease 
the amount of Zn excreted in manure (Rincker et al., 2005).  
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Figures and Tables 
Table 3-1. Composition of diets (as-fed basis) 
Item  Phase 1
1
 Phase 2
2
 
Ingredient, %   
Corn 48.72 60.74 
Soybean meal (46.5% CP) 29.01 35.00 
Spray-dried whey 15.00 --- 
Select menhaden fish meal 3.75 --- 
Monocalcium P (21% P) 1.05 1.60 
Limestone 0.70 1.10 
Salt 0.33 0.33 
Vitamin premix
3
 0.25 0.25 
Trace mineral premix
4
 0.15 0.15 
L-Lys HCl 0.30 0.30 
DL-Met 0.175 0.125 
L-Thr 0.125 0.110 
Cornstarch
5
 0.435 0.307 
Total 100 100 
      
Calculated analysis     
SID
6
 amino acids, %     
Lys 1.41 1.31 
Ile:Lys  60 63 
Leu:Lys 120 129 
Met:Lys 36 33 
Met & Cys:Lys 58 58 
Thr:Lys 62 62 
Trp:Lys 17 18 
Val:Lys  65 69 
Total Lys, % 1.55 1.45 
ME, kcal/kg 3,296 3,296 
SID Lys:ME, g/Mcal 4.28 3.97 
CP, % 22.3 21.9 
Ca, % 0.88 0.85 
P, % 0.78 0.75 
Available P, % 0.50 0.42 
1
Pigs were fed Phase 1 from d 0 to 14 (Exp. 1, 2, and 3).
 
2
Pigs were fed Phase 2 from d 14 to 28 in Exp. 1 and 2 and from d 14 to 42 in Exp. 3.  
3
Vitamin premix provided per kg of complete feed: 11,023 IU of vitamin A, 1,377 IU of vitamin D, 
44.1 IU of vitamin E, 4.4 mg of vitamin K, 0.04 mg of vitamin B12, 50.0 mg of niacin, 27.6 mg of 
pantothenic acid, and 8.3 mg of riboflavin.  
4
Trace mineral premix provided per kg of complete feed: 16.5 mg of Cu from CuSO4·5H20, 0.30 mg of 
I as C2H2(NH2)2·2HI, 165 mg of Fe as FeSO4H2O, 39.7 mg of Mn as MnSO4·H20, 0.30 mg of Se as 
Na2SeO3, and 165 mg of Zn as ZnSO4.   
5
Cornstarch was replaced with zinc oxide, tri-basic copper chloride, and copper sulfate to formulate 
treatment diets. 
6
Standardized ileal digestible. 
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Table 3-2. Analyzed chemical composition of diets (Exp. 1)
1
 
Added Cu
2
: No No No Yes Yes Yes 
Added Zn
3
: No Medium High No Medium High 
Phase 1
4 
            
   Zn, ppm 212 (196)
6
 1,472 (1,696) 2,519 (3,196) 190 (196) 1,431 (1,696) 2,831 (3,196) 
   Cu, ppm 23 (25) 22 (25) 24 (25) 196 (175) 170 (175) 191 (175) 
Phase 2
5 
            
   Zn, ppm 217 (194) 1,201 (1,194) 1,993 (2,194) 427 (194) 840 (1,194) 1,713 (2,194) 
   Cu, ppm 26 (25) 19 (25) 63 (25) 124 (175) 137 (175) 169 (175) 
1
A total of 180 weanling pigs (initially 5.7 kg and 21 d of age, PIC TR4 × 1050) were used in a 28-d experiment.
 
2
Added Cu from tri-basic copper chloride was supplied at no (0 ppm) or yes (150 ppm) levels above that provided by the 
trace mineral premix (16.5 ppm Cu). 
3
Added Zn from zinc oxide was supplied at no (0 ppm), medium (1,500 ppm in phase 1 and 1,000 in phase 2), or high 
(3,000 ppm in phase 1 and 2,000 in phase 2) levels above the 165 ppm Zn provided by trace mineral premix.  
4
Pigs were fed phase 1 from d 0 to 14.  
5
Pigs were fed phase 2 from d 14 to 28. 
6
Values in parentheses indicate the calculated value.  
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Table 3-3. Analyzed chemical composition of diets (Exp. 2)
1
 
Added Zn
2
: No No No Yes Yes Yes 
Cu source
3
: None TBCC CuSO4 None TBCC CuSO4 
Phase 1
4
             
   Zn, ppm 286 (196)
6
 183 (196) 197 (196) 2,798 (3,196) 2,721 (3,196) 2,599 (3,196) 
   Cu, ppm 28 (25) 152 (150) 149 (150) 27 (25) 156 (150) 141 (150) 
Phase 2
5
             
   Zn, ppm 183 (194) 229 (194) 176 (194) 2,360 (2,194) 1,897 (2,194) 1,930 (2,194) 
   Cu, ppm 25 (25) 178 (150) 188 (150) 48 (25) 140 (150) 144 (150) 
1
A total of 180 weanling pigs (initially 6.0 kg and 21 d of age, PIC 1050) were used in this 28-d experiment. 
2
Added Zn from zinc oxide was supplied at no (0 ppm) or yes (3,000 ppm in phase 1 and 2,000 ppm in phase 2) levels above 
the 165 ppm Zn provided by the trace mineral premix.  
3
Copper sources were none, tri-basic copper chloride (TBCC, 125 ppm Cu), and copper sulfate (CuSO4, 125 ppm Cu) and were 
supplemented above the 16.5 ppm Cu provided by the trace mineral premix.  
4
Pigs were fed phase 1 from d 0 to 14.  
5
Pigs were fed phase 2 from d 14 to 28. 
6
Values in parentheses indicate the calculated value. 
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Table 3-4. Analyzed chemical composition of diets (Exp. 3)
1
 
Added Cu
2
: No Yes No Yes 
Added Zn
3
: No No Yes Yes 
Phase 1
4
 
    Zn, ppm 69 (196)
6 
286 (196) 3,031 (3,196) 3,099 (3,196) 
Cu, ppm 74 (26) 161 (151) 11 (26) 183 (151) 
Phase 2
5
 
    Zn, ppm 204 (194) 256 (194) 1,823 (2,194) 1,819 (2,194) 
Cu, ppm 19 (25) 162 (150) 26 (25) 180 (150) 
1
A total of 216 weanling pigs (PIC, initially 6.2 kg and 21 d of age, PIC TR4 × 1050) were 
used in a 42-d experiment. 
2
Added Cu from copper sulfate was supplied at no (0 ppm) or yes (125 ppm) levels above the 
16.5 ppm Cu provided by the trace mineral premix. 
3
Added Zn from zinc oxide was supplied at no (0 ppm) or yes (3,000 ppm in phase 1 and 
2,000 in phase 2) levels above the 165 ppm Zn provided by the trace mineral premix. 
4
Pigs were fed Phase 1 from d 0 to 14. 
5
Pigs were fed Phase 2 from d 14 to 42.  
6
Values in parentheses indicate the calculated value. 
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Table 3-5. Effects of zinc oxide and tri-basic copper chloride on weanling pig performance (Exp. 1)
1
 
                Probability, P < 
Added Cu
2
: No No No Yes Yes Yes   Zinc × 
Copper 
    Zinc  
Added Zn
3
: No Medium High No Medium High SEM Copper Zinc linear quadratic 
Initial wt, kg 5.6 5.7 5.7 5.7 5.7 5.7 0.34 0.45 0.29 0.40 0.26 0.45 
d 0 to 14             
ADG, g 157 180 226 212 205 239 18.7 0.30 0.01 0.004 0.002 0.18 
ADFI, g 198 220 276 254 257 281 18.3 0.26 0.02 0.006 0.003 0.29 
G:F 0.79 0.80 0.82 0.83 0.79 0.85 0.035 0.60 0.36 0.44 0.42 0.32 
d 14 to 28             
ADG, g 475 500 526 523 525 552 25.7 0.78 0.03 0.10 0.04 0.68 
ADFI, g 670 697 755 731 742 795 37.9 0.87 0.008 0.005 0.002 0.32 
G:F 0.71 0.72 0.70 0.72 0.71 0.70 0.012 0.71 0.90 0.23 0.17 0.30 
d 0 to 28             
ADG, g 316 340 376 367 365 393 20.6 0.38 0.007 0.008 0.003 0.34 
ADFI, g 434 458 515 492 500 534 26.7 0.43 0.005 0.002 0.001 0.26 
G:F 0.73 0.74 0.73 0.75 0.73 0.74 0.009 0.29 0.49 0.94 0.75 0.89 
Final wt, kg 14.5 15.2 16.2 15.9 15.9 17.0 0.85 0.61 0.006 0.006 0.003 0.29 
1
A total of 180 weanling pigs (initially 5.7 kg and 21 d of age, PIC TR4 × 1050) were used in this 28-d experiment. 
2
Added Cu from tri-basic copper chloride was supplied at no (0 ppm) or yes (150 ppm) levels above the 16.5 ppm Cu provided by 
the trace mineral premix. 
3
Added Zn from zinc oxide was supplied at no (0 ppm), medium (1,500 ppm in phase 1 and 1,000 in phase 2), or high (3,000 ppm in 
phase 1 and 2,000 in phase 2) levels above the 165 ppm Zn provided by trace mineral premix.   
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Table 3-6. Effects of zinc oxide and tri-basic copper chloride on plasma mineral concentrations of weanling pigs (Exp. 1)
1
 
                Probability, P < 
Added Cu
2
: No No No Yes Yes Yes   
Zinc × 
Copper 
    Zinc  
Added Zn
3
: No Medium High No Medium High SEM Copper Zinc Linear Quadratic 
Plasma mineral concentrations
4
, µg/mL                      
Cu 1.88 1.88 1.81 1.81 1.98 1.89 0.102 0.58 0.63 0.57 0.97 0.30 
Zn 0.64 0.77 1.08 0.81 0.81 0.93 0.063 0.03 0.68 0.001 0.001 0.14 
P 0.070 0.083 0.085 0.081 0.080 0.077 0.0024 0.003 0.95 0.05 0.03 0.21 
1
A total of 180 weanling pigs (initially 5.7 kg and 21 d of age, PIC TR4 × 1050) were used in this 28-d experiment. 
2
Added Cu from tri-basic copper chloride was supplied at no (0 ppm) or yes (150 ppm) levels above the 16.5 ppm Cu provided by the trace 
mineral premix. 
3
Added Zn from zinc oxide was supplied at no (0 ppm), medium (1,500 ppm in phase 1 and 1,000 in phase 2), or high (3,000 ppm in phase 
1 and 2,000 in phase 2) levels above the 165 ppm Zn provided by trace mineral premix.   
4
Plasma was collected on d 14 from 2 pigs per pen (10 pigs/trt). 
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Table 3-7. Effects of zinc oxide, tri-basic copper chloride, and copper sulfate on weanling pig performance (Exp. 2)
1
 
                Probability, P < 
                      Copper effects 
Added Zn
2
: No No No Yes Yes Yes   Zinc × 
Copper 
    None vs. CuSO4 vs. 
TBCC Cu source
3
: None TBCC CuSO4 None TBCC CuSO4 SEM Zinc Copper CuSO4  TBCC  
Initial wt, kg 6.0 6.0 6.0 6.0 6.0 6.0 0.31 0.89 0.94 0.95 0.78 0.78 0.99 
d 0 to 14                           
ADG, g 149 168 209 205 208 261 18.3 0.86 0.001 0.002 0.001 0.49 0.004 
ADFI, g 214 217 251 237 243 283 18.1 0.95 0.02 0.01 0.007 0.77 0.01 
G:F 0.69 0.77 0.83 0.86 0.85 0.92 0.027 0.21 0.001 0.01 0.002 0.22 0.04 
d 14 to 28                           
ADG, g 443 471 468 440 487 496 22.1 0.74 0.40 0.11 0.06 0.08 0.88 
ADFI, g 714 734 697 733 767 791 25.8 0.21 0.01 0.47 0.37 0.24 0.78 
G:F 0.62 0.64 0.67 0.60 0.64 0.63 0.017 0.56 0.10 0.05 0.02 0.08 0.57 
d 0 to 28                           
ADG, g 288 319 338 320 348 379 18.3 0.92 0.01 0.01 0.001 0.006 0.11 
ADFI, g 450 475 474 480 505 537 20.6 0.46 0.004 0.05 0.02 0.12 0.33 
G:F 0.64 0.67 0.71 0.66 0.69 0.70 0.017 0.54 0.45 0.01 0.002 0.09 0.11 
Final wt, kg 14.4 14.9 15.4 15.1 15.7 16.6 0.70 0.85 0.02 0.03 0.01 0.22 0.11 
1
A total of 180 weanling pigs (initially 6.0 kg and 21 d of age, PIC 1050) were used in this 28-d experiment. 
2
Added Zn from zinc oxide was supplied at no (0 ppm) or yes (3,000 ppm in phase 1 and 2,000 ppm in phase 2) levels above the 165 ppm 
Zn provided by the trace mineral premix. 
3
Copper sources were none, tri-basic copper chloride (TBCC, 125 ppm Cu), and copper sulfate (CuSO4, 125 ppm Cu) and were 
supplemented above the 16.5 ppm Cu provided by the trace mineral premix.  
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Table 3-8. Effects of zinc oxide, tri-basic copper chloride, and copper sulfate on plasma mineral concentrations of weanling 
pigs (Exp. 2)
1
 
                Probability, P < 
                      Copper effects 
Added Zn
2
: No No No Yes Yes Yes  
Zinc × 
Copper 
  None vs. 
CuSO4 vs. 
TBCC Cu source
3
: None TBCC CuSO4 None TBCC CuSO4 SEM Zinc Copper CuSO4 TBCC 
Plasma mineral concentrations
4
, µg/mL                       
d 14                           
Cu 1.73 1.68 1.47 1.66 1.60 1.61 0.072 0.26 0.99 0.12 0.05 0.49 0.18 
Zn 0.68 0.63 0.60 1.11 1.12 1.21 0.059 0.31 0.001 0.88 0.84 0.77 0.62 
P 0.064 0.063 0.063 0.061 0.063 0.065 0.0024 0.67 0.82 0.69 0.42 0.87 0.52 
d 28                           
Cu 1.78 1.88 1.56 1.75 1.61 1.82 0.085 0.02 0.86 0.71 0.42 0.83 0.56 
Zn 0.87 0.89 0.87 0.90 0.95 0.96 0.040 0.72 0.09 0.69 0.50 0.42 0.90 
P 0.074 0.073 0.073 0.072 0.075 0.070 0.0021 0.48 0.42 0.52 0.48 0.68 0.26 
1
A total of 180 weanling pigs (initially 13.2 lb and 21 d of age, PIC) were used in this 28-d experiment. 
2
Added Zn from zinc oxide was supplied at no (0 ppm) or yes (3,000 ppm from d 0 to 14 and 2,000 from d 14 to 28) levels to the basal diet 
(165 ppm Zn). 
3
Copper sources were none, tri-basic copper chloride (TBCC, 125 ppm Cu), and copper sulfate (CuSO4, 125 ppm Cu). 
4
Plasma was collected from the same two pigs on d 14 and 28 (12 pigs/trt). 
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Table 3-9. Effects of zinc oxide and copper sulfate on weanling pig growth performance (Exp. 3)
1
 
        
Probability, P< 
Phase 1 diet
2
: Control Cu Zn Cu and Zn Zn Cu and Zn 
 
Zinc × 
Copper 
  
Phase 2 diet
3
: Control Cu Zn Cu and Zn Cu Cu SEM Zinc Copper 
Initial wt, kg 6.2 6.2 6.2 6.2 6.2 6.2 0.33 0.12 0.49 0.59 
d 0 to 14 
          
ADG, g 146
a
 182
b
 212
bc
 222
c
 217
bc
 222
c
 13.3 0.23 0.001 0.14 
ADFI, g 220
a
 261
b
 256
ab
 274
b
 267
b
 274
b
 14.7 0.25 0.04 0.07 
G:F 0.67
a
 0.70
a
 0.82
b
 0.81
b
 0.81
b
 0.81
b
 0.022 0.35 0.001 0.73 
wt on d 14, kg 8.2
a
 8.7
ab
 9.2
bc
 9.3
c
 9.2
bc
 9.3
c
 0.43 0.22 0.001 0.14 
d 14 to 28 
          
ADG, g 468
a
 533
c
 481
ab
 551
c
 544
c
 512
bc
 21.3 0.85 0.29 0.001 
ADFI, g 656
a
 729
bc
 705
ab
 779
c
 749
bc
 717
abc
 31.2 0.99 0.04 0.003 
G:F 0.72
a
 0.73
a
 0.68
b
 0.71
ab
 0.73
a
 0.71
a
 0.010 0.74 0.02 0.06 
d 28 to 42 
          
ADG, g 705
a
 734
ab
 733
ab
 713
ab
 743
b
 725
ab
 18.4 0.06 0.77 0.69 
ADFI, g 1163
a
 1243
b
 1214
ab
 1231
b
 1247
b
 1233
b
 40.9 0.17 0.40 0.04 
G:F 0.61
a
 0.59 0.60
ab
 0.58
c
 0.60
abc
 0.59
bc
 0.010 0.66 0.22 0.004 
d 14 to 42 
          
ADG, g 586
a
 634
c
 605
ab
 632
bc
 643
c
 618
bc
 17.9 0.32 0.39 0.001 
ADFI, g 910
a
 986
b
 956
ab
 1005
b
 998
b
 975
b
 34.3 0.47 0.10 0.003 
G:F 0.65 0.64 0.63 0.63 0.65 0.64 0.008 0.97 0.04 0.55 
d 0 to 42 
          
ADG, g 440
a
 483
bc
 473
b
 495
bc
 501
c
 486
bc
 14.9 0.30 0.03 0.003 
ADFI, g 680
a
 745
b
 720
ab
 761
b
 754
b
 741
b
 27.0 0.47 0.09 0.004 
G:F 0.65 0.65 0.66 0.65 0.67 0.66 0.008 0.65 0.46 0.68 
Final wt, kg 24.6
a
 26.5
b
 26.2
b
 27.0
b
 27.2
b
 26.9
b
 0.86 0.19 0.02 0.004 
1
A total of 216 weanling pigs (PIC, initially 13.6 lb and 21 d of age) were used in a 42-d experiment with 6 pens per treatment. 
2
Phase 1 diets were fed from d 0 to 14 after weaning: control (basal diet with no added Cu or Zn), Cu (125 ppm added Cu from copper sulfate), 
Zn (3,000 ppm added Zn from zinc oxide), and Cu and Zn (125 ppm added Cu from copper sulfate and 3,000 ppm added Zn from zinc oxide). 
3
Phase 2 diets were fed from d 14 to 42 after weaning: control (basal diet with no added Cu or Zn), Cu (125 ppm added Cu from copper sulfate), 
Zn (2,000 ppm added Zn from zinc oxide), and Cu and Zn (125 ppm added Cu from copper sulfate and 2,000 ppm added Zn from zinc oxide).  
abc
Within a row, means without a common superscript differ (P < 0.05). 
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Table 3-10. Effects of zinc oxide and copper sulfate on plasma mineral concentrations of weanling pigs (Exp. 3)
1
 
        
Probability, P< 
Phase 1 diet
2
: Control Cu Zn Cu and Zn Zn Cu and Zn 
 
Zinc × 
Copper 
  
Phase 2 diet
3
: Control Cu Zn Cu and Zn Cu Cu SEM Zinc Copper 
Plasma mineral concentrations, µg/mL 
        
d 14 
          
Cu 1.87 1.89 1.86 1.88 1.75 1.86 0.082 0.68 0.51 0.42 
Zn 0.53
a
 0.55
a
 0.95
c
 0.93
c
 0.74
b
 0.73
b
 0.066 0.81 0.001 0.92 
P 0.084
ab
 0.083
a
 0.086
ab
 0.086
ab
 0.094
b
 0.086
ab
 0.0042 0.71 0.17 0.28 
d 42 
          
Cu 1.94 2.13 2.06 1.97 1.97 2.10 0.077 0.08 0.78 0.54 
Zn 1.04
a
 1.08
a
 1.24
b
 1.12
ab
 1.13
ab
 1.06
a
 0.043 0.07 0.01 0.42 
P 0.092
a
 0.089
a
 0.092
a
 0.092
a
 0.098
b
 0.088
a
 0.0022 0.42 0.38 0.38 
1
A total of 216 weanling pigs (PIC, initially 13.6 lb and 21 d of age) were used in a 42-d experiment with 6 pens per treatment. 
2
Phase 1 diets were fed from d 0 to 14 after weaning: control (basal diet with no added Cu or Zn), Cu (125 ppm added Cu from copper sulfate), 
Zn (3,000 ppm added Zn from zinc oxide), and Cu and Zn (125 ppm added Cu from copper sulfate and 3,000 ppm added Zn from zinc oxide). 
3
Phase 2 diets were fed from d 14 to 42 after weaning: control (basal diet with no added Cu or Zn), Cu (125 ppm added Cu from copper sulfate), 
Zn (2,000 ppm added Zn from zinc oxide), and Cu and Zn (125 ppm added Cu from copper sulfate and 2,000 ppm added Zn from zinc oxide).  
abc
Within a row, means without a common superscript differ (P < 0.05). 
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CHAPTER 4 - Effects of copper sulfate, zinc oxide, and an in-feed 
antibiotic combination on weanling pig growth and antibiotic 
resistance rate for fecal Escherichia coli 
Abstract 
A total of 180 weanling pigs (PIC TR4 ×1050, initially 5.0 kg and 21 d of age) were used 
in a 42-d growth trial to compare the effects of supplemental Zn, Cu, and in-feed antimicrobial 
combination on weanling pig growth and Escherichia coli excretion and antibiotic resistance. 
There were 5 dietary treatments with 6 pens per treatments and 5 pigs per pen. Treatments were 
arranged as a 2 × 2 factorial with main effects of added Cu from CuSO4 (0 or 125 ppm) and 
added Zn from ZnO (0 or 3,000 ppm from d 0 to 14 and 0 or 2,000 ppm from d 14 to 42) along 
with an additional treatment of an in-feed antibiotic that provided neomycin (55 ppm) and 
oxytetracycline (55 ppm). The trace mineral premix added to all diets provided 165 ppm Zn from 
zinc sulfate and 16.5 ppm Cu from CuSO4. Fecal samples were collected from 3 pigs per pen on 
d 14 and 42 to determine total coliform and E. coli counts as well as E. coli antibiotic resistance 
rates. Pigs fed added ZnO had increased (P < 0.05) ADG, G:F, and tended to have improved (P 
< 0.09) ADFI from d 0 to 14. From d 14 to 42, pigs fed added ZnO had poorer (P = 0.006) G:F 
than pigs fed no added ZnO, and pigs fed added CuSO4 had improved (P < 0.04) G:F compared 
with those fed no added CuSO4. From d 14 to 42 and over the entire trial, a trend for a Cu × Zn 
interaction was observed (P < 0.10) for ADG as pigs fed added CuSO4 or ZnO had increased 
ADG over the control; however, when Zn and Cu were combined, growth rate was similar to that 
when each was added alone. No additive effects were observed in this experiment from feeding a 
combination of high dietary Cu and Zn. Addition of CuSO4, ZnO, or in-feed antibiotic had no 
effect (P > 0.22) on total coliform or E. coli concentrations on d 14 or 42. For d 14 isolates, Zn 
supplementation had no effect (P > 0.10) on E. coli resistance rate to chlortetracycline, 
neomycin, oxytetracycline, or tiamulin; however, Cu supplementation tended to increase (P < 
0.10) resistance to chlortetracycline and oxytetracycline. A Cu × Zn interaction was detected (P 
< 0.02) for E. coli resistance to chlortetracycline and neomycin from isolates on d 42. These 
interactions were caused by a decrease in resistance when CuSO4 was fed alone. High 
concentrations of ZnO improved performance in the early post-weaning period, whereas high 
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concentrations of CuSO4 increased growth in the later phase of the nursery. Although the 
resistance rate varied with dietary treatment, no clear pattern was detected. 
Key words: bacterial sensitivity, copper, growth, weanling pig, zinc 
Introduction 
Growth promoting or subtherapeutic levels of antibiotics are often added to nursery diets 
to increase growth rates (Cromwell, 2001). The use of antibiotics to promote growth has been 
controversial, due to the increased potential for antibiotic resistant bacteria. One alternative to 
antibiotics, would be to include pharmacological concentrations of either Zn or Cu in the diets of 
nursery pigs. Pharmacological Zn has been shown to increase growth rate (Hahn and Baker, 
1993; Smith et al., 1997; Carlson et al., 1999; Hill et al., 2001; Williams et al., 2005;) as well as 
increase stool firmness (Hill et al., 2000). Adding Cu to weanling pig diets also has been shown 
to enhance growth rates (Stahly et al., 1980; Cromwell et al., 1989; 1998; Hill et al., 2000). 
Historically, the use of high levels of both ZnO (3,000 ppm Zn) and CuSO4 (250 ppm Cu) has 
not shown additive effects (Smith et al., 1997; Hill et al., 2000).  However, Shelton et al. (2008) 
observed additive effects to supplementing pharmacological Zn and moderate concentrations of 
Cu (125 to 150 ppm) for 28-d post-weaning. Perez-Mendoza et al. (2008) also observed an 
improvement in growth the first 2 wk post-weaning with Cu supplementation in diets containing 
3,000 ppm of added Zn. 
Originally, it was thought pharmacological Cu or Zn could replace antibiotics and reduce 
the potential for antibiotic resistance bacteria. However, recent research has shown links between 
feeding increased concentrations of Cu and the development of Enterococci resistant to Cu as 
well as to the antibiotics vancomycin and erythromycin (Hasman and Aarestrup, 2002). In 
addition, Cu resistant E. coli isolates have been collected from pigs fed CuSO4 by Tetaz and 
Luke (1983). Therefore, our objective was to evaluate the growth effects of Cu, Zn, and 
antibiotic supplementation during the nursery stage, as well as determine differences in antibiotic 
sensitivity and excretion of fecal E. coli. 
Materials and Methods 
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General 
The protocol used in this experiment was approved by the Kansas State University 
Institutional Animal Care and Use Committee. The study was conducted at the Kansas State 
University Swine Teaching and Research Center, Manhattan.  
Animals 
A total of 180 weanling pigs (PIC, Hendersonville, TN, TR4 ×1050, initially 5.0 kg and 
21 d of age) were used in a 42-d growth trial. Pigs were allotted to pens by initial BW, and pens 
were assigned to treatments in a randomized complete block design with initial body weight used 
to establish blocks. There were 6 pens per treatment with 5 pigs per pen. Treatments were 
arranged as a 2 × 2 factorial with main effects of added Cu from CuSO4 (0 or 125 ppm) and 
added Zn from ZnO (0 or 3,000 ppm from d 0 to 14 and 0 or 2,000 ppm from d 14 to 42) along 
with an additional treatment of an in-feed antibiotic that provided 55 ppm of  neomycin and 
oxytetracycline (Penfield Animal Health, Omaha, NE). The trace mineral premix used in all diets 
supplied a base level of 165 ppm Zn from zinc sulfate and 16.5 ppm Cu from CuSO4. The diets 
were fed in 2 phases: Phase 1 from d 0 to 14 and Phase 2 from d 14 to 42 (Table 1). Phase 1 and 
2 diets were fed in meal form and formulated to contain 1.41% and 1.31% standardized ileal 
digestible lysine, respectively. Phase 1 diets contained 15% spray-dried whey and 3.75% fish 
meal, and Phase 2 diets were corn-soybean meal based without any specialty protein sources. All 
other nutrients were formulated to meet or exceed NRC (1998) requirements. Treatment diets 
were prepared by replacing corn starch with ZnO, CuSO4, or in-feed antibiotic. Diets samples 
were taken and analyzed for Cu and Zn concentrations (Table 2). Samples were digested with 
HNO3 and H2O2 and then analyzed for Cu and Zn by the atomic absorption spectrophotometric 
method (AOAC, 2000). Calculated dietary Cu and Zn concentrations were determined using 
amounts added by the trace mineral premix, values for dietary ingredients from NRC (1998), and 
any added Cu or Zn based on dietary treatment.  
Weights and feed disappearance were measured every 14 d to determine ADG, ADFI, 
and G:F. Each pen contained a 4-hole dry self-feeder and a nipple waterer to provide ad libitum 
access to feed and water. Pens had wire-mesh floor and allowed for approximately 0.36 m
2
 per 
pig. 
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Fecal collection and analysis 
On d 14 and 42, fecal samples were collected by rectal massage from 3 randomly selected 
pigs per pen. Fecal samples were diluted within a gram-negative broth, and then plated on 
MacConkey agar. Plates were placed in an incubator at 37°C for 6 h and then counted to 
determine the number of colony forming units per g of sample for both E. coli and total 
coliforms. One E. coli colony per sample was then isolated and retained for further analysis. 
Minimum inhibitory concentrations (MIC) of antibiotics were then determined on each isolate by 
the micro-broth dilution method (CLSI, 2002). The antibiotics evaluated included 
chlortetracycline, neomycin, oxytetracycline, and tiamulin. The MIC for each isolate was 
compared with published MIC values to determine whether each isolate was resistant or 
susceptible. Isolates were classified as resistant if the MIC was 16 µg/mL or higher for 
oxytetracycline, chlortetracycline, and neomycin and 32 µg/mL or higher for tiamulin. Finally, a 
pen resistant rate was calculated on the basis of the resistance for each pen’s 3 isolates. 
Statistical Analysis 
Pen was used as the experimental unit for all analyses, and data were analyzed using the 
MIXED procedure in SAS (SAS Institute Inc., Cary, NC). Main effects and potential interactions 
for added dietary Cu and Zn were tested using contrast statements. Bacterial counts were log 
transformed to achieve normality. Individual treatments were compared using the least square 
means differences. Pair-wise comparison was also used to test the difference between treatment 
means. Main effects and treatment comparisons were considered significant if their P-values 
were < 0.05 and trends if their P-values were < 0.10. 
Results 
Over the first phase (d 0 to 14), pigs fed added dietary ZnO had improved (P < 0.05) 
ADG and G:F (Table 3). Dietary Zn additions also tended to increase (P = 0.09) ADFI. The 
addition of CuSO4 did not affect (P > 0.10) ADG or ADFI; however, G:F was reduced (P = 
0.05) from d 0 to 14 compared with pigs fed no added Cu. Also, no improvements (P > 0. 59) in 
ADG, ADFI, or G:F were observed for pigs supplemented with in-feed antibiotics compared 
with pigs fed no added Zn or Cu.  
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From d 14 to 28, no improvements in ADG or G:F were observed (P > 0.10) from 
supplementing dietary Cu or Zn. However, a trend for a Cu × Zn interaction was detected (P = 
0.07) for ADFI. This interaction was due to increased ADFI when either Cu or Zn were used 
independently over the control; however, when Cu and Zn were used in combination, feed intake 
was intermediate to that of each used singularly. Pigs fed in-feed antibiotics had increased (P = 
0.01) ADFI and tended to have increased (P = 0.10) ADG over that of pigs fed no added Zn or 
Cu.  
From d 28 to 42, supplemental ZnO and/or CuSO4  did not influence (P > 0.10) ADG or 
ADFI. However, a trend for improved G:F was observed (P < 0.06) with CuSO4 addition, and a 
trend for worse G:F was observed (P < 0.08) with ZnO addition. The in-feed antibiotic had no 
effect (P > 0.10) on ADG, ADFI, or G:F compared with pigs fed the control diet.  
Over the entire Phase 2 (d 14 to 42), a trend (P = 0.10) for a Cu × Zn interaction was 
detected for ADG. Pigs fed supplemental CuSO4 or ZnO had increased ADG compared to pigs 
fed the control and the combination of minerals had reduced performance compared to the use of 
each independently. Pigs fed additional ZnO had poorer (P = 0.006) G:F and a trend for 
increased (P = 0.07) ADFI compared to pigs not receiving additional ZnO. Pigs fed 
supplemental CuSO4 had improved (P = 0.04) G:F but ADG and ADFI (P > 0.10) were not 
influenced. Antibiotic addition did not improve (P > 0.10) ADG, ADFI, or G:F compared with 
control pigs.  
Overall, a trend for a Cu × Zn interaction was detected (P = 0.09) for ADG. The addition 
of supplemental Cu or Zn increased ADG over the control; however, when Cu and Zn were 
combined, pigs had reduced growth compared with that achieved when feeding each 
independently. Pharmacological concentrations of Zn also increased (P = 0.04) ADFI. However, 
pigs fed the in-feed antimicrobial did not have improved (P > 0.10) ADG, ADFI, or G:F. 
Fecal coliform and E. coli counts in feces were not affected (P > 0.10) by dietary 
addition of CuSO4, ZnO, or in-feed antimicrobials (Table 3). For d 14 isolates, dietary ZnO 
supplementation had no effect (P > 0.10) on the percentage of E. coli isolates classified as 
resistant for chlortetracycline, neomycin, oxytetracycline, or tiamulin. However, from d 14 
isolates, CuSO4 tended to increase (P < 0.10) the percentage of isolates resistant to 
chlortetracycline and oxytetracycline. Also, the in-feed antimicrobial tended to increase (P < 
0.10) the percentage of isolates resistant to chlortetracycline and oxytetracycline compared with 
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the controls. For d 42 isolates, a copper × zinc interaction was detected (P < 0.02) for E. coli 
resistance to chlortetracycline and neomycin. These interactions were related to a decrease in the 
percentage of isolates classified as resistant when Cu was fed alone. In-feed antibiotic and 
CuSO4 dietary additions also tended to increase (P < 0.09) the percentage of E. coli isolates 
resistant to tiamulin on d 42. 
Discussion 
In this study, from d 0 to 14, Zn supplementation increased ADG by 21.2 %. The 
increased growth was due to a 12.4 % increase in feed intake and a 7.4 % increase in G:F. 
Carlson et al. (1999) also observed increased growth rate when supplementing 3,000 ppm Zn 
from ZnO for the first 2 wk post-weaning in pigs of either traditional or early weaning ages. 
During the second phase of our trial, numerical increases in growth and feed intake were 
observed with Zn supplementation; yet they were not significant. In two studies published by 
Hahn and Baker (1993), ADG increased by 14.5 and 12.4 % with supplementation of 3,000 ppm 
Zn from ZnO, after weanling pigs had been placed on common starter diets for 7 d. Shelton et al. 
(2008) also observed increases in ADG of  12.6 and 10.8 % when supplementing 
pharmacological concentrations of Zn for 28-d. In contrast to the positive responses, Tokach et 
al. (1992), Hedemann et al. (2006), and two studies by Smith et al. (1997) observed no effect of 
supplementing pharmacological concentrations of Zn for 14-d post-weaning.  
In this trial, Cu supplementation at 125 ppm from CuSO4 had no effect on ADG or ADFI 
during the initial phase. Likewise, Roof and Mahan (1982) also no growth promotion from 
adding 125 ppm Cu for the first 14-d post-weaning. During the second phase (d 14 to 42), 
feeding added CuSO4 alone increased ADG as compared with the control and the combination of 
Zn and Cu produced intermediate results to Cu alone and the control. Smith et al. (1997) 
observed similar results where CuSO4 added alone or in combination with ZnO increased growth 
rate as compared to control pigs; however, growth from adding either CuSO4 treatments were 
lower than the performance of the treatment containing ZnO alone. However, the optimal level 
of added Cu in weanling pig diets has varied between trials.  Cromwell (2001) concluded the 
most efficacious level for weanling pigs is 200 to 250 ppm Cu from CuSO4 by pooling results 
from 23 studies at the University of Kentucky with pigs weighing from 8 to 20 kg. Cromwell 
(2001) reported 11.9% improvement in growth and a 4.5% improvement in G:F with added Cu at 
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200 to 250 ppm from CuSO4. However, adding Cu as 125 ppm from CuSO4 produced 75% the 
growth response achieved with 250 ppm (Cromwell et al., 1989). 
Minimal advantages were observed in this study for adding an in-feed antibiotic 
combination. Other studies have shown much greater responses to additions of growth promoting 
concentrations of antibiotics (Cromwell, 2001). Woodworth et al. (2005) observed a 7.2% 
increase in ADG in weanling pigs provided the same level of 55 ppm neomycin and 
oxytetracycline. Frantz et al. (2004) also observed increased performance in supplementing this 
in-feed antibiotic combination to weanling pigs; however, 154 ppm of neomycin and 
oxytetracycline was used in their study. Cromwell et al. (2001) also showed that pigs housed in 
research stations have a lower response to including in-feed antimicrobials, which may have 
limited the response in this study.  
 This study did not show additive effects of adding ZnO and CuSO4 on the growth 
performance of weanling pigs. Similar to Hill et al. (2000) and Smith et al. (1997), adding ZnO 
or CuSO4 alone improved ADG compared with the control; however, the combination showed 
similar performance compared with the use of each singularly in these studies. This is in contrast 
with the additive effects of added Cu and Zn observed by Shelton et al. (2008). Perez-Mendoza 
et al. (2008) also observed an improvement in growth the first 2 wk post-weaning with Cu 
supplementation in diets containing 3,000 ppm of added Zn. The results from this present trial 
also showed optimal responses to added Zn- in initial diets post-weaning, followed by added Cu 
in later diets. This would minimize any excess feed costs economics costs from Cu and Zn 
supplementation that do not offer growth advantages. A second benefit would be to minimize the 
level of excreted Zn and Cu. Rincker et al. (2005) showed that Zn excretion increases after 
approximately 9 d of feeding pharmacological Zn as the body stores become maximized. The 
accumulation of Zn in soil has been shown to hinder crop production (Takkar and Mann, 1978; 
Chaney, 1993). DeRouchey et al. (2002) evaluated nutrient contents of swine lagoons in Kansas 
and showed that while Zn concentrations are increased in lagoons from nursery facilities, the 
concentration is only 2.5 times greater than from finishing lagoons. Therefore, by only 
supplementing Zn in the early diets and Cu in later diets, producers can take advantage of the 
growth promotion effects, remove the added diet costs, and minimize Zn excretions. 
The modes of action for Zn supplementation are unknown; however, several hypotheses 
have been proposed. Poulsen (1989) showed that pharmacological concentrations of Zn 
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prevented E. coli diarrhea in the weanling pigs. However, research has shown adding ZnO in the 
diet does not alter the level of E. coli excreted in fecal material (Jensen-Waern et al., 1998; Pulz 
and Carlson, 2007). This would be in agreement with our study where neither Cu or Zn 
supplementation affected the number of either E. coli or coliforms excreted in feces. Woodworth 
(1999) suggested that while Zn does not affect the number of E. coli, instead it may prevent E. 
coli from adhering to the gut wall and allowing for greater absorption of nutrients. Diarrhea was 
not observed for any pigs in the present study.   
The modes of action for adding Cu have not been defined. Hedemann et al. (2006) 
showed that dietary added Cu had no effect on intestinal morphology. It has also been shown that 
Cu supplementation promotes growth independently of antibiotic additions (Stahly et al., 1980; 
Roof and Mahan, 1982), indicating it may have a different mode of action than antibiotics.  
Bacterial resistance can be expressed either intrinsically or by acquired resistance. Each 
bacterial species has particular antibiotics that it is intrinsically resistant to (Klare et al., 2003). 
For example, E. coli are intrinsically resistant to glycopeptide antibiotics due to their outer 
membrane being impermeable to the glycopeptides, such as vancomycin (Quintiliani and 
Courvan, 1995). Acquired resistance is achieved from either the mutation of a certain gene 
within that microorganism or by horizontal gene transfer (Catry et al., 2003). Horizontal gene 
transfer occurs when genes are transferred from a donor to recipient bacterium by either 
conjugation, transformation, or transduction. The mechanisms associated with resistance are 
varied and may differ depending on antibiotic; however, the same resistance mechanism may 
also be applicable for several antibiotics (Catry et al., 2003). For example, Danish research has 
shown a correlation between copper resistance and vancomycin and erythromycin resistance 
(Hasman and Aarestrup, 2002) in Enterococcus faecium. The plasmid associated with Cu 
resistance can also initiate resistance for vancomycin and erythromycin in Enterococci.  
The impact of Cu and Zn supplementation on E. coli resistance to antibiotics has not been 
well defined. Overall, there was a high prevalence of antibiotic resistant E. coli throughout our 
study. Our study was conducted at a site where feed grade antibiotics are commonly utilized in 
nursery diets to improve growth performance, which could have induced the overall high level or 
resistance. At the same time antibiotics are produced by microorganisms and antibiotic resistance 
may occur even without their inclusion in the feed (Mathew, 2003). The Cu × Zn interaction for 
E. coli resistance to chlortetracycline and neomycin from isolates on d 42 is an interesting 
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observation from this study. There is not a biological reason why resistance would drop 
dramatically when additional dietary copper was fed alone. It may have been an effect of 
sampling, as only 3 isolates per pen were used to determine resistance rate. Holt (2008) observed 
no resistant E. coli isolates to neomycin when either pharmacological Zn or Cu were provided. 
They utilized pigs from a herd where antibiotics had been discontinued for 32 years and 
therefore fecal E. coli  were sensitive to most gram-negative antibiotics. Holt (2008) did detect 
an increase in the proportion of resistant E. coli  isolates to tylosin when Cu was added to 
nursery pig diets at 240 ppm compared with pigs fed control diets or those with pharmalogical 
levels of Zn. Although the resistance rate to some antibiotics tended to increase with Cu 
supplementation in our study, no clear pattern was detected.  
In conclusion, this trial did not show additive effects to supplementing Cu and Zn in 
weanling pig diets. We observed minimal increases in the proportion of resistant E. coli isolates 
when pharmacological Cu and/or Zn were provided in the diet; however, that may be masked 
due to the high proportion of resistant bacteria for all animals. Fecal E. coli concentrations were 
unaltered by pharmacological Cu or Zn. Zinc additions increased growth primarily in the early 
period after weaning, and Cu supplementation improved performance in later periods. This 
suggests that growth performance may be affected even greater if pharmacological Zn was 
provided in the early weaning rations, followed by supplemental Cu during later portions in the 
nursery.  
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Figures and Tables 
Table 4-1. Composition of diets (as-fed basis)
1
 
Item  Phase 1
2
 Phase 2
3
 
Ingredient, %   
Corn 48.72 60.74 
Soybean meal (46.5% CP) 29.01 35.00 
Spray-dried whey 15.00 --- 
Select menhaden fish meal 3.75 --- 
Monocalcium P (21% P) 1.05 1.60 
Limestone 0.70 1.10 
Salt 0.33 0.33 
Vitamin premix
4
 0.25 0.25 
Trace mineral premix
5
 0.15 0.15 
L-Lys HCl 0.30 0.30 
DL-Met 0.175 0.125 
L-Thr 0.125 0.110 
Corn starch
6
 0.435 0.307 
Total 100 100 
      
Calculated analysis     
SID
7
 amino acids, %     
Lys 1.41 1.31 
Ile:Lys  60 63 
Leu:Lys  120 129 
Met:Lys  36 33 
Met & Cys:Lys  58 58 
Thr:lys  62 62 
Trp:Lys  17 18 
Val:Lys  65 69 
Total lysine, % 1.55 1.45 
ME, kcal/kg 3,296 3,296 
SID lysine:ME ratio, g/Mcal 4.28 3.97 
CP, % 22.3 21.9 
Ca, % 0.88 0.85 
P, % 0.78 0.75 
Available P, % 0.50 0.42 
1
A total of 180 weanling pigs (PIC, initially 5.0 kg and 21 d of age) were used in a 42-d experiment 
with 6 pens per treatment and 5 pigs per pen. 
2
Pigs were fed Phase 1 from d 0 to 14.
 
3
Pigs were fed Phase 2 from d 14 to 42. 
4
Vitamin premix provided per kg of complete feed: 11,023 IU of vitamin A, 1,377 IU of vitamin D, 
44.1 IU of vitamin E, 4.4 mg of vitamin K, 0.04 mg of vitamin B12, 50.0 mg of niacin, 27.6 mg of 
pantothenic acid, and 8.3 mg of riboflavin.  
5
Trace mineral premix provided per kg of complete feed: 16.5 mg of Cu from CuSO4·5H20, 0.30 mg of 
I as C2H2(NH2)2·2HI, 165 mg of Fe as FeSO4H2O, 39.7 mg of Mn as MnSO4·H20, 0.30 mg of Se as 
Na2SeO3, and 165 mg of Zn as ZnSO4  
6
Cornstarch was replaced with ZnO, CuSO4, or Neo/Oxy 10/10 (Penfield Animal Health, Omaha, NE) 
to create treatment diets. 
7
Standardized ileal digestible. 
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Table 4-2. Analyzed chemical composition of diets, ppm
1
 
 
Treatment
2
 
 
Control Cu Zn Cu + Zn Antibiotic 
Phase 1
3
 
    
 
Zn 196 (196)
5 
215 (196) 2,750 (3,196) 3,246 (3,196) 223 (196) 
Cu 25 (26) 179 (151) 48 (26) 198 (151) 41 (26) 
Phase 2
4
 
    
 
Zn 254 (194) 228 (194) 1,836 (2,194) 1,958 (2,194) 316 (194) 
Cu 28 (25) 178 (150) 35 (25) 169 (150) 36 (25) 
1
A total of 180 weanling pigs (PIC, initially 5.0 kg and 21 d of age) were used in a 42-d experiment with 6 pens per 
treatment and 5 pigs per pen. 
2
Treatments included: control (basal diet with no added Cu or Zn), Cu (125 ppm of added Cu from CuSO4), Zn (3,000 ppm 
from d 0 to 14 and 2,000 ppm from d 14 to 28 of added Zn from ZnO), Cu and Zn (125 ppm of added Cu from CuSO4 and 
3,000 ppm from d 0 to 14 and 2,000 ppm from d 14 to 28 of added Zn from ZnO), and antibiotic (55 ppm of neomycin and 
oxytetracycline from Neo/Oxy 10/10; Penfield Animal Health, Omaha, NE).  
3
Pigs were fed Phase 1 from d 0 to 14. 
4
Pigs were fed Phase 2 from d 14 to 42.  
5
Values in parentheses indicate the calculated value.
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Table 4-3. Effects of zinc oxide, copper sulfate, and antibiotic combination on weanling pig growth performance
1
 
 
       
Probability, P< 
   
Treatment
2
 
   
Zinc × 
Copper 
  
Antibiotic 
vs. control 
 
Control Cu Zn Cu + Zn Antibiotic SEM Zinc Copper 
Initial wt, kg 5.0 5.0 5.0 5.0 5.0 0.02 0.82 0.86 0.91 0.89 
D0 to 14 
          
ADG, g 169
a
 184
ab
 218
b
 210
b
 180
ab
 18.7 0.45 0.02 0.84 0.60 
ADFI, g 191
a
 220
ab
 227
ab
 235
b
 199
ab
 17.7 0.46 0.09 0.20 0.71 
G:F 0.90
ab
 0.85
b
 0.98
a
 0.90
ab
 0.92
ab
 0.030 0.70 0.05 0.05 0.70 
wt on d 14, kg 7.3
a
 7.5
ab
 8.0
b
 7.9
ab
 7.5
ab
 0.29 0.45 0.03 0.86 0.60 
D 14 to 28 
          
ADG, g 419 460 455 450 454 17.9 0.13 0.38 0.24 0.10 
ADFI, g 571
a
 615
ab
 643
b
 621
b
 637
b
 21.8 0.07 0.03 0.52 0.01 
G:F 0.71 0.73 0.69 0.70 0.69 0.014 0.97 0.15 0.33 0.42 
D 28 to 42 
          
ADG, g 685 727 704 713 675 25.1 0.40 0.89 0.19 0.72 
ADFI, g 1,018 1,043 1,077 1,057 1,009 39.3 0.45 0.23 0.93 0.83 
G:F 0.67
ab
 0.69
a
 0.65
b
 0.67
ab
 0.66
ab
 0.013 0.85 0.08 0.06 0.93 
D 14 to 42 
          
ADG, g 547
a
 591
b
 577
ab
 574
ab
 562
ab
 17.9 0.10 0.63 0.14 0.45 
ADFI, g 790
a
 828
ab
 858
b
 836
ab
 819
ab
 27.0 0.15 0.07 0.69 0.29 
G:F 0.69
ab
 0.71
a
 0.67
b
 0.68
b
 0.68
b
 0.010 0.60 0.006 0.04 0.56 
D 0 to 42 
          
ADG, g 418
a
 454
b
 456
b
 450
ab
 432
ab
 15.3 0.09 0.15 0.21 0.39 
ADFI, g 586
a
 623
ab
 646
b
 635
b
 609
ab
 21.1 0.14 0.04 0.41 0.29 
G:F 0.71 0.72 0.70 0.70 0.70 0.009 0.47 0.12 0.30 0.75 
Final wt, kg 22.7 24.1 24.2 23.9 23.5 0.72 0.15 0.24 0.32 0.30 
1
A total of 180 weanling pigs (PIC, initially 5.0 kg and 21 d of age) were used in a 42-d experiment with 6 pens per treatment and 5 pigs per pen. 
2
Treatments included: control (basal diet with no added Cu or Zn), Cu (125 ppm of added Cu from CuSO4), Zn (3,000 ppm from d 0 to 14 and 
2,000 ppm from d 14 to 28 of added Zn from ZnO), Cu and Zn (125 ppm of added Cu from CuSO4 and 3,000 ppm from d 0 to 14 and 2,000 ppm 
from d 14 to 28 of added Zn from ZnO), and antibiotic (55 ppm of neomycin and oxytetracycline from Neo/Oxy 10/10; Penfield Animal Health, 
Omaha, NE).  
ab
Within a row, means without a common superscript differ (P < 0.05). 
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Table 4-4. Effects of zinc oxide, copper sulfate, and antibiotic combination on fecal bacteria counts and E. coli antibiotic resistance
1
 
       
Probability, P< 
   
Treatment
2
 
   
Zinc × 
Copper 
  
Antibiotic 
vs. control 
 
Control Cu Zn Cu + Zn Antibiotic SEM Zinc Copper 
Coliform counts, Log10 CFU/g         
D 14 6.2 5.8 6.2 5.6 6.0 0.50 0.82 0.81 0.25 0.68 
D 42 5.5 4.9 5.1 5.0 4.9 0.49 0.52 0.72 0.30 0.23 
E. coli count, Log10 CFU/g         
D 14 5.9 5.3 5.9 5.4 5.6 0.53 0.91 0.95 0.25 0.62 
D 42 4.7 4.2 4.8 4.6 4.3 0.52 0.78 0.59 0.38 0.49 
Antibiotic-resistant E. coli isolates, % 
       
D 14 isolates 
          
Chlortetracycline
3
 56 89 61 78 92 14.1 0.57 0.85 0.10 0.09 
Neomycin
3
 33 33 28 28 44 15.0 1.00 0.68 1.00 0.56 
Oxytetracycline
3
 72
ab
 94
ab
 67
a
 89
ab
 100
b
 11.2 1.00 0.63 0.07 0.10 
Tiamulin
4
 100 94 100 100 94 3.5 0.44 0.44 0.44 0.28 
D 42 isolates 
          
Chlortetracycline
3
 83
b
 47
a
 81
b
 89
b
 81
b
 9.6 0.02 0.03 0.10 0.81 
Neomycin
3
 78
b
 25
a
 67
b
 83
b
 81
b
 11.2 0.01 0.05 0.13 0.87 
Oxytetracycline
3
 94 72 86 89 94 8.4 0.16 0.63 0.27 1.00 
Tiamulin
4
 90 100 94 100 100 3.7 0.59 0.59 0.06 0.09 
1
A total of 180 weanling pigs (PIC, initially 5.0 kg and 21 d of age) were used in a 42-d experiment with 6 pens per treatment and 5 pigs per pen. 
2
Treatments included: control (basal diet with no added Cu or Zn), Cu (125 ppm of added Cu from CuSO4), Zn (3,000 ppm from d 0 to 14 and 2,000 
ppm from d 14 to 28 of added Zn from ZnO), Cu and Zn (125 ppm of added Cu from CuSO4 and 3,000 ppm from d 0 to 14 and 2,000 ppm from d 
14 to 28 of added Zn from ZnO), and antibiotic (55 ppm of neomycin and oxytetracycline from Neo/Oxy 10/10; Penfield Animal Health, Omaha, 
NE).  
3
Isolates with a minimum inhibitory concentration of 16 µg/mL or higher for this antibiotic were considered resistant.  
4
Isolates with a minimum inhibitory concentration of 32 µg/mL or higher for this antibiotic were considered resistant.  
ab
Within a row, means without a common superscript differ (P < 0.05). 
 
